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ABSTRACT 
 
3D BIOPRINTING SYSTEMS FOR THE STUDY OF MAMMARY DEVELOPMENT AND 
TUMORIGENESIS 
 
John Anderson Reid 
Old Dominion University, 2018 
Co-Directors: Dr. Patrick C. Sachs 
Dr. Dean J. Krusienski 
Understanding the microenvironmental factors that control cell function, differentiation, 
and stem cell renewal represent the forefront of developmental and cancer biology1. To accurately 
recreate and model these dynamic interactions in vitro requires both precision-controlled 
deposition of multiple cell types and well-defined three-dimensional (3D) extracellular matrix 
(ECM). To achieve this goal, we hypothesized that accessible bioprinting technology would 
eliminate the experimental inconsistency and random cell-organoid formation associated with 
manual cell-matrix embedding techniques commonly used for 3D, in vitro cell cultures. The first 
objective of this study was to adapt a commercially-available, 3D printer into a 3D bioprinter. 
Goal-based computer simulations were used to identify, evaluate, and optimize the performance 
of a 3D bioprinting system. Implementing these findings yielded a bioprinting system with reduced 
needle clogging and single cell print resolution. The minimal disruption of cell function was 
confirmed by the retention of pluripotency marker TRA-1-81 in bioprinted human induced 
pluripotent stem cells (hiPSCs) 7-days post-printing. This system was then used to investigate cell 
behavior during the initial stages of organoid-structure formation by generating 3D bioprinted 
arrays of individual, mammary epithelial cell (MEC) organoid-structures. This quantifiable, 3D 
bioprinting approach, was able to direct the ‘self-assembly’ of large MEC structures through 
organoid ‘fusion’ events among individual, bioprinted organoids along the printing template. 
Bioprinting maintained experimental consistency among multiple 3D scaffolds and experimental 
conditions, and presents the capability to generate high-fidelity, 3D arrays with multiple cell types. 
Compared to manual matrix embedding, bioprinted, co-culture experiments, containing normal 
MECs and breast cancer cell lines, significantly increased the ability to generate chimeric 
(tumor/normal) MEC structures. Thus, bioprinting stands highly qualified to investigate the role 
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The cell is a wonderfully complex and precise little mechanism; 
          disease is but disorder of this mechanism. 
The aim of medicine is to prevent or repair such disorders. 
The aim of biology is to understand the cellular machinery. 





The focus of most tissue engineering research tries to identify the unique processes that 
enable cells to make tissues with a different form and function. It turns out that a substantial amount 
of gene expression in cells originates from signals in the micro-environment. However, as with 
most things, our ability to study this has been limited due to a lack of available technology. For 
example, because the iconic, flat-surface of a plastic petri-dish fails to mimic real-world 
conditions, cells grown in two-dimensional (2D) environments do not carry out their tissue-
specific functions. As a result, we now understand that the structure of a tissue or organ is 
indispensable for its function. This is important because most of the information about cell biology 
we have today originated from 2D cultures. Thus, many treatment options currently available to 
clinicians were derived from flat-plastic, 2D, monolayer cultures. So, while numerous genomic 
and gene expression arrays can provide evidence of a cell’s status or identity, these results mean 
little unless we can provide the cells with a 3D environment that recapitulates the ‘context’ 
presented in the real-world structure. While animal models have provided a large amount of 
evidence of the importance of tissue microenvironments in regulating cellular behavior, they limit 
our ability to identify the specific features involved in this process. Thus, a huge challenge for 
breast cancer research comes from the need to incorporate ‘context’ into in vitro research models.  
From computational fluid dynamics (CFD) to additive manufacturing, the main goal of this 
work attempts to implement engineering technology and techniques to design 3D, in vitro models 
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which better recapitulate the in vivo situation. To achieve this, we hypothesized that accessible 
bioprinting technology would eliminate the experimental inconsistency and random cell-organoid 
formation associated with manual cell-matrix embedding techniques commonly used for 3D, in 
vitro cell cultures. Specifically, to improve upon our current understanding of the cell-cell 
interactions associated with human tissue micro-environments, this work attempted to use 
accessible 3D bioprinting techniques to increase our ability to create ‘contextual’ information by 
reliably patterning multiple cell types inside 3D, in vitro models using human based ‘bio-inks’. 
We began this study by designing an accessible, 3D bioprinter to deposit small cell quantities 
inside 3D environments. Next, we used this system to determine the necessary parameters to 
reliably generate MEC organoid-structures in a 3D environment. Last, we investigated the ability 
to reliably generate ‘chimeric’ organoids composed of ‘normal’ MECs and tumorigenic cell lines. 
Chapter 1 begins with a summary of MEC biology. This sets fourth information about the 
growth and development of the mammary gland. This information provides a general 
understanding of the dynamic relationships among the unique cell populations, physical 
environment, and cyclical nature of mammary gland growth and regulation. Using these criteria 
as a guide, the next portion presents the current ability of 3D cell culture methods to generate in 
vitro models of mammary gland biology. This includes a general overview of a typical 3D cell 
culture experiment. Chapter 1 concludes with a description of how limitations of current 3D cell 
culture methods negatively impact the ability to standardize 3D cell culture research.  
Chapter 2 provides the first contribution of the dissertation, which is the design and 
optimization of an extrusion device to reliably print small quantities of cells. This includes detailed 
information about the hardware components of the system, an overview of a typical 3D bioprinting 
printing experiment, and additional variables related to tailoring the instrument for the specific 
needs of a given experiment. 
Chapter 3 details the use of the bioprinting system to identify the necessary printing 
parameters to reliably control MEC organoid formation. This chapter provides the second 
contribution of this dissertation, which is the identification of the unique printing parameters 
related to MEC organoid formation. By standardizing the cell quantity and proximity among 
individual cell-deposits, a uniform rate of organoid formation was achieved in bioprinted arrays of 
MECs. Identifying these printing parameters enabled the development of a more reliable and 
practical 3D culture model for studying MEC morphogenesis and epithelial biology. 
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Chapter 4 presents the utilization of a bioprinting apparatus to reliably generate chimeric, 
luminal-structures of normal MCF-12A cells and tumorigenic cells. The characterization of these 
interactions represents the third main contribution of this dissertation. The comparative analysis 
of subcellular proteins of normal, tumorigenic, and chimeric (tumor/normal) organoids contributed 
to a better understanding of the aberrant signaling associated with the neoplastic state. Overall, 
Chapters 2, 3, and 4 illustrate the common features of bioprinter operation and important variables 
for designing experimental protocols using bioprinters. 
Chapter 5 presents the conclusion of these studies, along with a discussion and summary 
of the main results of the dissertation, as well as proposing future extensions of this research. Using 
bioprinting techniques to reliably deposit user-specified cell quantities in defined spatial-
coordinates, our results indicated MEC organoid formation rates are dependent on the quantity of 
local cell numbers. Furthermore, bioprinting experiments designed to sequentially vary inter-
organoid spacing indicated a time sensitive window of developmental plasticity; the resulting 
organoid geometry can be manipulated to match any desired geometry and size when initial cell-
deposits were maintained within this spacing window. Lastly, we show accessible bioprinting 
techniques provide a reliable method to pattern multiple cell types inside 3D, in vitro cultures. This 
enabled a significant increase in the ability to reliably generate ‘chimeric’ cell organoids. Thus, 
bioprinting technology appears well suited to recreate the ‘contextual’ cues to further current 
research.   
Here we show 3D bioprinting devices contain the capacity to reliably harness the 
remarkable affinity of living cells to spontaneously ‘self-organize’ into structures large enough for 
transplantation. As the power of any given scientific technology is rooted in the ability to reliably 
recreate experimental results, 3D bioprinting stands as an optimal technology to address the ‘big-
data’ questions of many biological systems. Beginning with deciphering the microenvironmental 
variables present in the in vivo condition, bioprinting will illuminate the regulatory information for 
proper differentiation of cells, stem cell renewal, and eventually the development of complete 





1.2 Mammary Gland Formation 
From the bumblebee bat to the blue whale, the mammary gland distinguishes mammals 
from all other animals. Beyond protocols of modern taxonomy, the tissue structure and function 
of the mammary gland are also unique because of the cyclical nature of the cell-cell and cell-
extracellular matrix (ECM) interactions which also depend on the developmental stage and 
reproductive history of the mammal. For this reason, the mammary gland presents an optimal 
model system to study developmental biology. Studies of mammary gland development have 
presented valuable insights into the mechanisms regulating cell and tissue polarity, cell fate 
specification, branching morphogenesis, and the involution of a functional organ. Investigating 
these developmental programs are of interest to cancer biologists; many of the dysregulated 
pathways and processes observed throughout breast cancer progression mimic those observed 
during normal mammary gland development and tissue remodeling. However, the study of this 
system also stimulates a compelling desire to comprehend and solve the problem of breast cancer. 
Breast cancer affects 1 in 8 women in the United States. Thus, at one time or another, almost every 
family will have to deal with its consequences. We begin this overview by highlighting the 
different cell types that make up the mammary gland, with a specific focus on mammary gland 
‘stem/progenitor cells’. We also discuss the external factors within the mammary gland 
microenvironment, which influence cell fate and function.  
While rodent and human mammary glands have important structural variances, the mouse 
is a tractable, model organism, with well-researched methods and established protocols that have 
provided many insightful studies2. It is not surprising that much of our knowledge of mammary 
gland development, function, and tumorigenesis has emerged from investigations in the mouse. 
Both the human and rodent mammary gland are comprised of two types of epithelial cells: apically 
oriented luminal epithelial cells that line the ducts, and basally oriented myoepithelial cells. 
Luminal cells predominantly express keratins 8 and 18 (Ck8, Ck18), and are responsible for 
producing casein and other milk proteins. Myoepithelial cells predominantly express keratins 5 
and 14 (Ck5, Ck14), as well as alpha smooth muscle actin which mediates their contractile 
function3. For this reason, myoepithelial cells are viewed as a hybrid of smooth muscle cells and 
epithelial cells because their contraction functions to cause secretion of milk during lactation4. 
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During embryogenesis, initial mammary development begins with the emergence of 
epithelial buds from ectoderm into mammary mesenchyme to form a rudimentary system of ducts, 
which continue a moderate rate of elongation after birth and with increases in body weight. 
Specifically, the first visible evidence of the mouse mammary gland is a subtle enlargement of the 
epidermis in the embryo on the E10 to E11. This single layered ectoderm enlarges to form the 
mammary lines, which extend from the anterior limb bud in the hindlimb to the posterior limb bud 
on the forelimb on both sides3. The individual mammary buds are formed as the epidermal cells in 
this band migrate to separate “centers of concentration” on the E12. The lens-shaped, multilayered, 
ectodermal structures called placodes then rise slightly above the surrounding ectoderm. The 
placodes then become bulbs of epithelial cells distinct from the surrounding epidermis. This 
separation event defines the future locations of the nipples and the accompanying mammary ducts. 
Mesenchymal cells around the bud condense and become the mammary mesenchyme. Between 
E12-16, the mammary rudiment maintains a slow growth. However, androgen receptor activation 
in the mesenchyme of male embryos between E13.5 and E15.5 signals for the degradation of the 
mammary buds3. On the other hand, female mammary gland development continues at E15.5, 
wherein the mammary rudiment starts to elongate by rapid cellular proliferation in the bud, leading 
to the formation of a sprout that invades the fat pad precursor3. Up until the last days of gestation, 
the mammary epithelium penetrates the prospective fat pad to create the branching trees of the 
early gland5. In fact, the mammary gland of the 19-day fetus contains the fundamental structures 
present in the adult virgin mammary gland6. 
In rodents, the prepubertal mammary gland consists of long, infrequently branched ducts 
terminated by highly proliferative structures, called terminal end buds (TEBs)5,7. The TEB 
structures in the mammary gland are characterized by their strategic location at the tips of ducts. 
TEBs are comprised of two main compartments, a single, basally-positioned layer of cap-cells, 
which stays in contact with the thin layer of basal lamina and differentiate into myoepithelial cells 
as the duct elongates, and the inner compartment, consisting of a multi-cellular layer around 4-6 
cells in thickness which form the bulk of the TEB known as the body-cell layer8. It is believed that 
the processes of ductal elongation and complex branching of the mammary gland originate in 
mammary stem cells located in the TEB9.  
Considered the ‘engine’ of ductal elongation, TEBs penetrate and expand into the 
mammary fat pad and undergo regular bifurcation events to give rise to the tree-like pattern of the 
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primary mammary ductal tree10. This period of ductal expansion is the result of intensive mitotic 
activity in mammary TEBs11. Secondary and tertiary ducts sprout from primary ducts to form the 
characteristic ductal arborization observed in mature virgins. The bulbous, epithelial structures at 
the advancing edge of the TEB appear to be specialized to permit rapid penetration of the 
surrounding fatty stroma. The posterior regions of TEBs provide a supply of differentiating ductal 
and myoepithelial cells for elongation of subtending ducts12. Branching morphogenesis results 
from the collective advancement of luminal epithelial cells, whereas myoepithelial cells appear to 
restrain elongating ducts. Duct initiation requires proliferation, Rac, and myosin light-chain kinase, 
whereas repolarization to a bilayer depends on Rho kinase13. In addition to linear growth, 
mammary TEBs branch dichotomously at regular intervals, thereby generating the rudimentary 
patterning of the gland8,14. By turning to avoid competing tissue, they generate regular spacing 
between ductal elements. Once the TEBs near the edge of the fat pad, or when scarce gland-free 
stroma is available for continued growth, TEBs regress into blunt-ended, ductal termini, and their 
subtending ducts become mitotically inactive15. Importantly, these structures do not exhibit the 
high-degree of proliferation or the histological structures of active TEBs16. 
Breast tissue morphogenesis in the adult organism is coupled to the periodicity of the 
mammalian reproductive cycle7,17,18. Throughout puberty and pregnancy, unique cell types are 
responsible for the mammary functions at each developmental phase19,20. However, branching 
morphogenetic processes dominate over those promoting differentiation or apoptosis during the 
estrous cycle, pregnancy and after parturition21. In contrast to the linear growth of ductal 
elongation, branching morphogenesis in pregnancy is followed by a radial growth and 
differentiation of ductal cells into lobular alveolar epithelium that produces milk after parturition. 
It should be noted that luminal cells of the duct also produce milk. After weaning, extensive ECM 
remodeling occurs concomitantly with tissue involution through the regulated apoptosis of lobular 
alveolar breast epithelium, and in the proliferation of adipocytes. This pattern of morphogenetic 
differentiation/involution is repeated throughout the reproductive life span of female mammals, 
and defines the cyclically regenerative capacity of normal adult breast tissue21. This process is 
currently thought to result from hierarchies of stem/progenitor cells within the luminal epithelial 
cell population and myoepithelial cells lining the ducts22. The regenerative ability of these cell 
types has been confirmed experimentally23. For example, when transplanted into cleared mammary 
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fat pads, these cell types can give rise to entire ‘clonally-derived’ mammary trees2,24,25. Thus the 
mammary gland epithelial compartment contains a mammary epithelial stem cell population24. 
1.2.1 Dynamic Relationship Between Mammary Tissue Structure and Function 
The continuum of secreted factors that make up the acellular fraction of the 3D 
microenvironment is known as the ECM. The ECM is composed of diverse substances, from 
macromolecules like collagens, fibronectin, laminins, to polysaccharides such as hyaluronan, and 
glycosaminoglycan. BM, a form of specialized ECM, surrounds all epithelia. Aside from structural 
support, the BM forms a mechanical connection between epithelial layers and nearby connective 
tissue. The BM also prevents epithelial cells from invading the connective tissue, while also 
preventing the invasion of surrounding stromal cells into the BM compartment. Laminin, a trimeric 
protein, interacts with itself, other components of the ECM, and proteins on epithelial cells. As 
such, it is considered the primary organizer of the BM. Type IV collagen provides the tensile 
strength of the BM through a network of fibers. Nidogen and perlecan link the collagen network 
to laminin. 
While numerous genomic and gene expression arrays can provide evidence of a cell’s 
status or identity, it is a fallacy to argue that genes alone determine and regulate the pattern of gene 
expression. It has been postulated that tissue-specific form and function are achieved by the 
dynamic interactions between the cell and its surrounding ECM. For example, normal organ 
architecture can act to suppress tumor growth, and prevent malignant phenotypes, despite gross 
genomic abnormalities26. As a result, we now understand that the microenvironmental structure of 
a tissue or organ is indispensable for its function.  
Outside the cell, the ECM functions to maintain the appropriate integrity and strength of 
the cell network, and the type and amount of cellular connection to the ECM. Inside the cell, cell 
adhesions serve as anchoring points between cells, and between the cell cytoskeleton and the ECM. 
Important to our current understanding of ECM in cellular processes is the crosstalk among the 
individual ‘inside’ and ‘outside’ components within these systems27. For example, in response to 
the presence of laminin, MECs upregulate expression of several connexin gap junction (GJ) 
proteins, which leads to an enhancement of gap junctional intercellular communications (GJIC)28. 
Thus, components of the ECM can alter aspects of the cell-interior through ‘outside-in’ processes. 
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Conversely, the cell can secrete and remodel the ECM through ‘inside-out’ processes29. 
Specifically, the nuclear compartment of the cell interacts with the cytoskeletal compartment, 
which interacts with the membrane compartment, which interacts with the extracellular world.  
Importantly, instead of a two-way street, where each component is an isolated, one-way traffic 
flow, the influence of ‘outside-in’ and ‘inside-out’ processes on gene expression are better 
represented as a traffic circle where both components converge and intersect to influence global 
traffic flow. The overall process is a dynamic, cross-talk which connects ECM-ECM receptor 
interactions to the cytoskeleton, to the nuclear matrix, chromatin and back again1. This phenomena 
is commonly dubbed ‘dynamic reciprocity’30. Thus, instead of a simple scaffold to host cell 
growth, the ECM is now viewed as an integral determinant of tissue specificity itself.  
1.2.2 Cell and Tissue Polarity 
Cells in all tissues and organs are asymmetrically organized. Likewise, the importance of 
proper maintenance of cell polarity in MECs is essential for their communication with the 
extracellular world, and the ability to produce and secrete milk proteins. Without correct polarity, 
fluids would not be transported to the appropriate compartments. Three different intercellular 
junction complexes function to create a polarized tissue: tight junctions, adherens junctions, and 
desmosomes31. These complexes hold epithelial cells together and attach cells to the BM. Tight 
junctions regulate the paracellular transport of ions and small molecules and serve to inhibit the 
mixing of proteins in the apical and basal compartments. Tight junctions are a network of strands 
that encircle the cell and interact with similar strands on neighboring cells, creating a seal around 
the cells. Intercellular tight junctions are stabilized by linkage to actin filaments. The two domains 
of MEC structures, the apical layer of luminal cells, and the basal myoepithelial cells, differ in 
protein and lipid composition, which is regulated by intercellular junctions and cytoskeletal 
organization. Even without myoepithelial cells, establishing apicobasal polarity and cell junctions 
can be achieved if cells are cultivated in the presence of exogeneous BM components, such as 
Matrigel (Geltrex), or on a flexible collagen I gel. In the latter case, as cell-cell contact is increased, 




The concept that cells are modulated by signals from their surrounding microenvironment 
is not new. How else can 10 trillion cells with the same genetic information make the numerous 
types of tissues, each with a different form and function? In tissues, multiple cell types serve 
distinct functions. The information presented here attempts to illustrate the fact that these functions 
are more dependent on the highly ordered, 3D geometrical context, than their individual genome. 
Also, as early as the 1960s, chimeric models using the stroma from one type of tissue co-cultured 
with epithelial cells from a different tissue have indicated the structure of an organ presents 
signaling information which is distinct from the genomic blueprint of the cell. Thus, a huge 
challenge for breast cancer research comes from the need to incorporate ‘context’ into research 
models. 
 1.3 The Use of 3D Culture Systems to Study Epithelial Biology  
1.3.1 History of 3D Culture Systems 
3D culture systems for generating organoid cultures of MECs inside collagen matrices 
were first introduced over four decades ago33-35. Standard 3D culture procedures involve either 
mixing dispersed MECs with ECM substrates prior to gelling (as described in Protocol 1), or by 
culturing cells on top of a pre-formed ECM gel. The encapsulated cells will then spontaneously 
‘self-assemble’ into organoids. The initial stage of this process is characterized by the ability of 
the epithelial cells to detect and sense points of contact with ECM surfaces through integrins and 
dystroglycans, and points of contact with neighboring cells through cadherins and desmosomes36. 
The presence of these initial contacts spontaneously activates a series of cell remodeling events, 
which results in the polarization of cells, i.e. the formation of basolateral and apical surfaces with 
an asymmetric distribution of membrane proteins37. For the purposes of this and other 3D MEC 
investigations, the term ‘MEC organoid’ was operationally defined as cell growth and proliferation 
which resulted in the formation of semi-organized multicellular structures with polarized cells 
facing an open lumen31,34,36,38,39. 
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1.3.2 Effect of Parameters on Cell Behavior in 3D Culture 
In 3D culture, multiple parameters operate together to affect both experimental outcomes 
and interpretation of experimental results. These parameters include cell type, cell-cell 
interactions, ECM composition, culture media, and an assortment of mechanical properties such 
as matrix stiffness and cell confinement (porosity)40-51. 3D culture models have highlighted the 
importance of matrix compliance for tissue-specific differentiation36. Matrix compliance differs 
dramatically between 2D and 3D cultures, and normal versus tumor tissues in vivo. The normal 
mammary gland has an elastic modulus of 167 ± 31 (Pa), the average tumor 4049 ± 938 (Pa), and 
2D tissue culture plastic (polystyrene) 2.78x109 (Pa)52. Therefore, it is not surprising that 
successful recapitulation of normal tissue morphogenesis is favored by matrix conditions with an 
elastic modulus that corresponds to normal tissues in vivo52. Indeed, cells invariably lose their 
differentiated phenotypes when grown on 2D tissue culture plastic33. However, these cells can 
regain their differentiated phenotypes if the microenvironment of the culture vessel is designed to 
mimic the cell’s normal, in vivo microenvironment1. Also, it is widely acknowledged that sources 
of ECM for 3D cell culture, such as collagen isolated from animal tissues and/or laminin rich 
extracellular matrix such as Matrigel, are subject to lot-to-lot variability, which has the potential 
to introduce experimental irregularities in the mechanical properties of 3D cell culture systems53. 
However, Matrigel or collagen can be modified by adjusting the gel thickness, gelling temperature, 
and concentration. 
Recent investigations of mammary ductal morphogenesis indicate collagen fiber density, 
diameter, and alignment play a key role in determining the shape of in vitro cultures of mammary 
epithelium54,55. Upon encapsulation, mammary cells cultured in collagen gels extend processes to 
‘sense’ and reorganize the surrounding meshwork for considerable distances (10-100µm) before 
pseudopod stabilization and mechanical interaction54. Following stable adhesion formation to 
ECM components, the mechanical interaction between individual cells and ECM results in the 
transmission of strain patterns which can extend through hundreds of microns of gel56-58. This 
applied mechanical strain leads collagen fibers to orient along the direction of the strain, which 
results in increased contact guidance59. This may explain why early studies found a preference for 
breast epithelial organoids to develop along tension lines between adjacent organoids within 
collagen gels60. Through what appears to be a positive feedback loop, a small alignment of fibers, 
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cells, tension, or the resistance to tension can be amplified into a robust, parallel orientation of 
cells and fibers54. Together, these findings suggest the developmental cues that define tissue form 
and function are derived from physical properties within the surrounding microenvironment and 
are rarely cell intrinsic. Delineating the role of these organizational features in tissue 
morphogenesis will lead to a better understanding of the coordinated cellular behaviors responsible 
for normal tissue formation across local and global spatial scales. 
Numerous examples have reported the considerable influence of physical parameters on 
tissue morphology in 3D cultures. Early work using primary mammary epithelial cells showed that 
cells plated on plastic or embedded in collagen gels that remain attached to the culture plate, lose 
the fully differentiated phenotype, along with the ability to produce the milk protein β-casein. 
However, cells could be induced to make β-casein if the collagen gel was initially detached from 
the culture dish, known as a ‘floating’ collagen gel32,33. Additionally, β-casein production could 
be rescued in cells embedded in attached gels, if the gels were detached (floated) from the culture 
surface33. Epithelial cell differentiation is not limited to floating gels; differentiated alveolar and 
ductal structures were found in collagen gels cast in thin-plastic inserts with a porous, flexible 
membrane bottom61. However, the MEC organoid phenotypes from this method were reported to 
be associated with distinct locations of the collagen gel, which may be related to minute variances 
in collagen matrix elasticity between the center and periphery of the gel59,61. The ability of physical 
parameters of 3D cultures to influence cellular differentiation has also been supported by 
experimental evidence linking attached collagen gels to a significant increase in Ki67, a marker of 
proliferation, when compared to cells in a floating gel of the same density62. Thus, the control of 
epithelial structures cannot be attributed to matrix composition alone. 
The ability of MECs to successfully differentiate appears to depend on their ability to 
contract the collagen gel. ROCK-mediated contractility diminished RHO activity in a floating 3D 
collagen gel and corresponded to a loss of FAK phosphorylated at Y397 localized to 3D matrix 
adhesions62. Further, when cells are cultured in high-concentration, floating collagen gels, Rho 
activity remains high, FAK phosphorylation is promoted, and differentiation/organoid formation 
is disrupted. These data suggest that increased ECM rigidity increases Rho activity which 
promotes epithelial proliferation, motility, and alters focal adhesion formation, all of which lead 
to a loss of the functional, differentiated organization required for proper organoid formation62. 
Together, these data suggest that the physical forces, such as the fibrillar organization of collagen 
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fiber reorganization, and the external influences of cell culture conditions can influence the 
development and maintenance of structural and functional differentiation of normal mammary 
epithelia.  
1.3.3 Summary 
The development and remodeling of the mammary gland is dependent on dynamic 
molecular, and mechanical pathways. Importantly, tissue architecture itself is a key component of 
the regulatory mechanisms that dictate cell growth and function35,63. To accurately recreate the in 
vivo environment, every individual component of in vitro models must be tuned for the system 
under study. The development of cancer is characterized by a loss of tissue architecture, loss of 
differentiation, and dysregulation of growth control, all of which result in the invasive and 
proliferative phenotype. Similarly, when the spatiotemporal coordination between extracellular 
cues and intracellular processes is disturbed, normal cellular behavior becomes deregulated, which 
often leads to malignant transformations. Therefore, in vitro, 3D models must accurately reflect 
the local microenvironment and cellular behaviors in normal tissues. 
1.4 Bioprinting Platforms in Biological Research 
1.4.1 3D Bioprinting 
3D bioprinting has gained recent attention as an investigative tool to alleviate some of the 
experimental inconsistencies and limitations frequently associated with manual methods of 3D cell 
culture64. The use of CAD technology to fabricate complex organs and materials of biological 
origin defines the core goal behind bioprinting technology. Current bio dispensing processes in 3D 
biofabrication utilize inkjet, microextrusion and laser-assisted printing65. However, commercially 
available bioprinting devices are not readily optimized for the unique research demands of 
individual labs, which have limited their widespread adoption into routine assays and procedures. 
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The greatest features when considering different bioprinting technologies are the print 
resolution, materials used during the printing process, the cell signaling pathways affected by the 
printing process, and the culture methods used. While inkjet and laser-based transfer are well 
suited to manipulate picoliter to nanoliter droplets at microscale resolution, they are not simple to 
use or maintain. For example, inkjet deposition techniques typically employ thermal or 
piezoelectric actuators. The nozzles in these actuators are cylindrically shaped with diameters 
around 50µm. It is also the case that traditional inkjet printers are only capable of printing liquids. 
That is to say, to form solid 3D structures, the printed liquid must be crosslinked after deposition. 
Crosslinking adds additional environmental stresses to the conditions that the cells must endure 
(pH changes, temperature changes etc.)66. Numerous variables must be controlled to maintain the 
high resolution of laser-based printers. These factors include the surface tension and wettability of 
the substrate, in addition to the air gap between the prepared solution and the collector substrate67. 
Additionally, each donor transport support or ‘ribbon’ must be prepared for each printed cell or 
hydrogel type. This equates to a time-consuming, preparatory sequence that is not ideal for routine 
experimentation in most research labs. 
1.4.2 Adapting Bioprinters to Meet Specific Research Demands 
Tissue engineering research requires custom materials and tailor-made fabrication 
methods, which are not easily addressed in closed-source systems. The bioprinting device and 
associated protocols described here were designed, manufactured, and tested to investigate our 
unique requirements to generate controlled-arrays of cells in 3D environments. This process 
involved investigating the potential use of ‘off-the-shelf’ 3D manufacturing systems for routine 
3D cell culture. First, the need to extrude microscopic sized particles through a small orifice is not 
just a problem for biologists using 3D bioprinters, but also for all living cells in cell-based printing. 
For this reason, the duration and amount of mechanical forces experienced by cells should be 
minimized during flow. 
Second, if the specified tolerance among the parts is appropriately maintained within a set 
standard, extrusion-based printing technologies can achieve resolutions way beyond that of 
routine, handheld pipetting. Ensuring the intended amount gets to the intended spatial region of 
the construct is paramount. For obvious reasons, these are intimately related to advances in 
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manufacturing technologies used in 3D printing devices. However, they are also related to 
matching the machine parameters to the desired experimental scale. That is to say, if a 50 ml 
syringe and a 1 ml syringe were placed on identical extrusion-based bioprinters, and both given an 
identical travel distance in the linear actuator located on the extrusion head, a greater amount of 
material will be extruded from the 50 ml syringe. Thus, the performance of extrusion-based 
systems is intimately related to the size and volume of material inside the syringe. 
Third, common 3D bioprinting operations fabricate tissue constructs using a layer-by-layer 
process. Yet, because they are mostly water, when gel components come out of a printer nozzle 
they do not always stay in their specified location. This severely limits the spatial resolution of 
cell-deposits in 3D constructs due to the inability to accurately control the location of cells during 
gel polymerization.  Furthermore, the rheological properties of any given substrate can affect 
printing operation. For example, shearing effects during the deposition process can impart 
destructive forces on the structural integrity of gel components. 
The physical properties of a substrate can also affect printability. For example, many 3D 
MEC cultures employ collagen or other mesh-forming materials as a primary scaffold. Yet, fibrous 
materials spontaneously ‘self-assemble’ to form aggregates, including those which function in vivo 
to form a plug, like the role of fibronectin and fibrin to prevent further blood loss during wound 
healing. Thus, it would only take a few collagen aggregates to occlude the narrow tip of a 10µm 
nozzle. Additionally, reliably patterning cells suspended inside highly-viscous ‘ink’ would require 
more extrusion force than extruding cells suspended in liquid cell-culture ‘media’. 
Some of the limitations of layer-by-layer manufacturing could be overcome if bioprinting 
operation were able to insert cells into a pre-formed, bio-scaffold that contained some self-healing 
properties. Using this method, one could easily see how layer-by-layer bioprinting operations 
could be complemented with a high-resolution injection device68,69.  
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1.4.3 Importance of the Tissue Microenvironment  
Despite significant increases and improvements in cancer research, nearly 95% of 
oncology drugs in clinical trials fail to receive Food and Drug Administration approval70. 
Additionally, despite the availability of potent chemotherapeutics against a wide variety of cancer 
types, some patients never achieve a long-lasting cure. The complete therapeutic elimination of 
tumor cells remains complicated due to the phenomena of tumor heterogeneity71,72. Part of this 
issue stems from the inability of preclinical models to accurately recapitulate the complexity of 
the disease state. These complexities originate from cancer cell-intrinsic signaling/cross talk, 
extrinsic interactions with other cell types, and multiple components of the tumor 
microenvironment73. In addition, the dynamic regulatory networks generated within these diverse 
cell populations are also influenced by unique zones within the tumor environment, each with 
various physical and chemical parameters71,74-76. 
Thus, in addition to matching matrix stiffness to comply with in vivo conditions, the 
maintenance and differentiation of the numerous mammary gland cell types is also dependent on 
the properties and features of the local tissue microenvironment. Biological phenomena observed 
during development require interactions among different components of a tissue; and the clear 
majority of these are seldom explained without addressing the contextual cues from the tissue-
level to the cell-level of organization77,78. Therefore, while they are generally informative, in vivo 
xenotransplantation assays of human cancers, and monoculture models of 3D tumor biology, such 
as tumor spheroids and tumor organoids, are incapable of incorporating the microenvironmental 








DESIGN RATIONALE, DEVELOPMENT, AND UTILIZATION OF A 3D 
BIOPRINTING DEVICE 
2.1 Overview 
The precision and repeatability offered by computer-aided design and computer-
numerically controlled techniques in biofabrication processes is quickly becoming an industry 
standard. However, many hurdles still exist before these techniques can be used in research 
laboratories for cellular and molecular biology applications. To circumvent the high-price barrier 
to entry of conventional bioprinters, 3D printed components were created for the adaptation of an 
'off-the-shelf' 3D printer. Extrusion-based bioprinting systems have been characterized by high 
development costs, injector clogging, difficulty achieving small cell number deposits, decreased 
cell viability, and altered cell function post-printing. To address these performance limitations, 
several microneedle geometries were developed to optimize ‘bio-ink’ flow. Goal-based, computer 
simulations indicated the needle geometries of conventional, commercially standardized, 'luer-
lock' syringe-needle systems cause many of the resolution issues plaguing conventional 
bioprinters. Among these, a short-tapered injector design with minimal cylindrical needle length 
was ideal to minimize cell strain and accretion. These geometries were experimentally quantified 
using pulled glass microcapillary pipettes and the modified, low-cost 3D printer. 
This systems performance validated computer-simulation models exhibiting: reduced 
clogging, single cell print resolution, and maintenance of cell viability without the use of a 
sacrificial vehicle. This system maintained the pluripotency of human induced pluripotent stem 
cells (hiPSCs) 7 days post-printing in Geltrex. We also show embryoid body differentiation of 
hiPSC by injection into differentiation-conducive environments, wherein we observed continuous 
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growth, emergence of various evaginations, and post-printing gene expression indicative of the 
presence of all three germ layers. These data demonstrate the benefits of using accessible, open-
sourced, 3D bioprinters to serve the individual needs of any laboratory interested in 3D cellular 
interactions and tissue engineering. 
2.2 Introduction 
Bioprinting enables the high-precision, high-accuracy, and high-throughput generation of 
biological constructs that can contain: ECM scaffolds, cells, and biochemical factors in 3D. Due 
to these advantages, bioprinters hold the promise of establishing culture conditions that more 
closely mimic the human in vivo microenvironment than animal models, and current 2D cell 
culture environments79,80. Specifically, great progress has been made in the field of tissue 
engineering and regenerative medicine due to the emergence of a wide range of 3D multifunctional 
devices which employ extrusion-based technologies to further the development of advanced 
materials that require proper pre/post-processing for the fabrication of 3D structures81-84. While 
capable of generating high-throughput experimental designs to answer difficult biological 
questions, the technology has remained inaccessible to most research labs due to the initial 
investment and routine, operational costs. Furthermore, the design and implementation of custom-
built 3D bioprinters yields high lab-to-lab variability resulting in unpredictable experimental 
outcomes, generating some unease surrounding their implementation. 
The dominant techniques in microextrusion bioprinting use valve-based pneumatic or gear-
driven actuator extrusion systems to drive cell suspensions out of a micro-needle tip. Numerous 
studies have noted needle diameters under 150μm are not ideal because they are prone to frequent 
needle clogging85,86. Naturally, the print resolutions of these systems are largely dependent on the 
diameter and flow rate at the needle tip. Therefore, despite having highly accurate/precise single-
μm positioning features, the majority of microextrusion bioprinters are limited to 150μm wide 
print resolutions. In addition to clogging, previous reports indicate process-induced damage can 
lead to a significant source of cell death and unexpected post-printing phenotypes87-93. Therefore, 
any design that alleviates clogging and process-induced damage, while simultaneously increasing 
print resolution to the sub-150μm level, would be highly advantageous. 
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Furthermore, the impact of these systems on more sensitive cell types has been 
understudied. One extremely promising cell type prone to defects upon physical manipulation is 
the induced pluripotent stem cell (iPSC). iPSCs are advantageous in both disease modeling and 
tissue engineering as they have the ability to self-renew indefinitely or differentiate into any cell 
type of all three germ layers94. A significant challenge for the implementation of iPSCs into 
bioprinting is the multivariate nature of the differentiation process. When culture conditions permit 
differentiation, iPSC clumps will initially form spheroids, which then differentiate into embryoid 
bodies (EBs) that resemble early stages of embryogenesis. It has been shown that the initial size 
of the EB aggregate is a critical factor in controlling differentiation95. However, few existing 
technologies are capable of reliably controlling the quantity of individual cells in a target location, 
and the overwhelming majority of current investigations rely on handheld pipetting. Additionally, 
mechanically induced stem cell differentiation has been attained through application of mechanical 
forces including stretch, strain, compression, and shear stress96. This awareness has led to the 
development of methods to encapsulate cells through the use of hydrogel-vehicle systems to alter 
the distribution of damaging mechanical forces experienced during flow. Yet, recent studies 
indicate these systems do not offer complete protection from damaging forces, and cell-vehicle 
interactions could ultimately lead to unwanted cell-fate determination post-printing66,97. Therefore, 
the successful use of iPSCs requires biofabrication techniques that not only minimize harmful 
forces and exposure to stress, but also concurrently select the appropriate culture conditions to 
achieve the desired, differentiated cellular product. 
Here we demonstrate the adaptation of a commercially available, 'off the shelf' extrusion-
based, 3D printer (Felix 3.0) into a functional, high-resolution, extrusion based 
bioprinter/bioplotter. Furthermore, we report a goal-based, computational modeling approach to 
optimize the biofabrication of high resolution, fragile cell transfer without the use of encapsulating 
hydrogels to maintain the pluripotency of printed hiPSCs. We experimentally quantified the 
functional limitations of micro-extrusion based bioprinting by exploring relationships among 
parameters such as micro-needle geometry, infusion flow rate, printed cell resolution, cell viability 
and the retention of a functional differentiation capacity. We show via both finite element method 
(FEM) and physical cell-extrusion bioprinting experiments that the use of deposition systems with 
a sharp reduction in inlet diameter coupled to a long, narrow microneedle (such as those found in 
'luer-lock' syringe systems) generate greater amounts of detrimental forces than those with a gently 
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tapered, conical needle geometry. We also demonstrate the ability of our system to print sensitive 
hiPSCs without affecting their pluripotency. With new maker movements taking hold98, the use of 
printable components for accessible bioprinting holds the possibility of making truly transparent, 
and transportable scientific advancements in this field a reality. By lowering the barrier of entry 
for these complex tools, research in laboratories across the world will be able to design studies to 
not only improve the engineering of tissues, but also improve the in vitro study of biological 
processes such as development and tumorigenesis. 
2.3 Materials and Methods 
2.3.1 Cell Culture 
Green fluorescent protein (GFP) labeled rat epithelial cells and GFP labeled MDA-MB-
468 mammary epithelial cells were cultured in a 75 cm2 flask in a mixture of Dulbecco's modified 
Eagle's medium and Ham's F12 medium (DMEM/F12), 10% FBS and 1% ABAM (ThermoFisher). 
MCF-12A cells were purchased from ATCC and cultured in 75 cm2 flask in DMEM/F12, 
supplemented with 20 ng ml−1 hEGF, 0.01 mg ml−1 bovine insulin, 500 ng ml−1 hydrocortisone, 
5% Horse Serum, 0.01 mg ml−1 bovine insulin and 1% ABAM. Established human induced 
pluripotent stem cells lines (hiPSC) were generated from BJ fibroblasts through sendai virus 
reprogramming99 and cultured on Geltrex matrix (ThermoFisher) with Essential 8 medium 
(ThermoFisher) and passaged manually with a pulled glass 'knife' to avoid culture induced 
genomic instability. All cells were cultured at 37.0 °C, and 5.0% CO2. 
2.3.2 Bioprinting System 
We have developed a microextrusion based bioprinting system that is capable of extruding 
biopolymer solutions and living cells for freeform construction of 3D tissue scaffolds. This was 
achieved by modifying a consumer-based 3D printer, Felix 3.0 (FELIXrobotics, NL). The machine 
has listed print resolutions of 13μm, 13μm, and 0.39μm for the x, y, and z axes, respectively. All 
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3D printed components of the deposition system were designed in-house using Solidworks CAD 
software and printed in PLA or ABS using the 3D printer. The deposition apparatus, designed to 
replace the plastic-extruding print head, mounts to the stock printer's x-axis mounting bracket. The 
apparatus is capable of housing a variety of tools through a library of part specific, 3D printed 
inserts. The system is powered by a NEMA 17 hybrid bipolar stepping motor with an integrated 
threaded rod (Pololu, USA, item no. 2268). The traveling nut moved 40μm per full step. The 
stepper motor has a 1.8° step angle (200 steps/revolution) and each phase draws 1.7 A at 2.8 V, 
allowing for a holding torque of 3.7 kg cm (51 oz-in). Therefore, 1 revolution equaled 8000μm of 
linear travel. The Felix 3.0's motor driver is capable of using 1/16th microstepping routines, which 
provided resolutions of 2.5nl. The internal backlash of the motor is ≤ 3°. An 8mm Simplicity® 
linear plain bearing (PCB Linear) and an 8-mm stainless steel rod (McMaster Car) provide support 
during linear displacements. Experiments were defined by user inputs in a custom Python and 
Matlab graphical user interface. The software allows the user to manually or automatically 
populate the wells of a specific plate with specific droplet properties in 3D. The program would 
also correct user operations that would place the needle tip outside the boundaries of the available 
print areas. The plotting locations and printing information was automatically converted into g-
code, loaded into the open-sourced 3D printer controller Repetier Host, v.1.0 and sent to the three-
axis microcontroller.  
2.3.3 Computational Modeling 
To quantify the relationship between fluid flows as a function of microneedle geometry, 
idealized needle geometry profiles were created in Solidworks Flow Simulation (Dassault 
Systems, FR) and Comsol Multiphysics. A goal-driven, computational analysis was solved 
iteratively until flow parameters converged to a certain solution/goal. The flow simulation utilized 
solution-adaptive mesh refinement by splitting the mesh cells in the high-gradient flow regions 
and merging cells in the low-gradient flow regions. The mesh was set to provide advanced, narrow-
channel refinement and optimized thin wall resolutions. The model was given conditions of steady, 
non-Newtonian flow. The fluid used in our experiments was given properties similar to blood. 
Three classes of needle geometries were created representative of the cylindrical needle geometry 
seen in stainless steel 'luer-lock' needles, a straight sided cone, or tapered profiles modeled as 
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hyperbolas, parabolas or ellipses in a similar manner to those seen in Martanto et al.100. The inlet 
diameter for all needle conditions equaled 1mm. The inlet volume boundary condition was based 
on a constant volumetric flow rate of 0.1mm3 s−1 (0.1 μl s−1). The diameter of the flow outlet for 
all simulated conditions equaled 60μm. The flow outlet boundary condition was set to standard 
atmospheric pressure, (101325 Pa). Our model conditions accounted for the effects of gravity on 
cell settling during needle inversion. We were able to specify wall conditions by specifying values 
for accretion rates and the normal and tangential coefficient of restitution. The model features from 
three idealized needle geometries that met our goal criteria (minimum shear rate, pressure, and 
needle diameter while maximizing flow rates) were then fabricated using a Sutter P97 
programmable pipette puller and experimentally quantified using our 3D printed, 3D bioprinter. 
An optical encoder provided measurement scales to confirm needle profiles by visual analysis 
using Matlab and ImageJ. 
2.3.4 Cell Viability Assay 
MCF-12A cells were suspended in media to a concentration of 1 × 106 cells ml–1. For all 
conditions, approximately 25μl of media was loaded into the needle at a rate of 10 μl min−1 and 
dispensed into wells of a 96 well plate at one of four rates: 100, 400, 600, and 1000 μl min−1. All 
four rates were repeated in three separate wells for a total of 12 wells per condition. Four needle 
conditions; no-tip (control), 28-gauge needle, straight cone, and long tapered needle were tested, 
giving a total of 48 wells. Post-printing, cells were maintained in a laboratory incubator at 37.0 
°C, 5.0% CO2. Viability was assessed 1 and 96 hours post-printing with AlamarBlue 
(ThermoFisher) by measuring absorbance at 570 nm on a UV–Vis spectrophotometer with 
SoftMax Pro 6.3. The sample mean viability was calculated and normalized to the initial viability 
of the no-tip control. Statistical significance was determined using one-way ANOVA with 






2.3.5 hiPSC Bioprinting and TRA-1-81 Staining of hiPSCs 
Twenty-four hours prior to printing, 50μl of a 1:1 mixture of growth factor reduced Geltrex 
and differentiation suppressive media (Essential 8) was added to 12 wells of a standard 96 well 
plate and stored in a laboratory incubator at 37.0 °C, 5.0% CO2. Before cell plotting, the plate was 
removed from the incubator and placed on the heated print bed (37.0 °C). Single cell suspensions 
of hiPSCs were obtained by rinsing pre-established, hiPSC containing wells with DMEM, 
followed by a 5-min incubation with Accutase (Sigma-Aldrich). Cells were then centrifuged at 
300 x g for 3 min; and the resulting pellet was diluted with essential 8 media to a concentration of 
4.5 × 106 cells per ml. Single cell suspensions of hiPSCs were then loaded into a pulled glass 
needle with a 40μm tip diameter at 10 μl min−1. The plotting routine was set to dispense a number 
of 100nl droplets 200μm (X, Y) apart and 250μm (Z) from the bottom of the plate. Post-printing, 
150μl of essential 8 media was overlaid on the gel, and the plate was incubated at 37.0 °C, 5.0% 
CO2 for 7 days. The overlaid media was changed every 24 hours for 7 days. After 7 days in culture, 
StainAlive TRA-1-81 antibody (Stemgent) was diluted to a concentration of 5 μg ml−1 in fresh cell 
culture medium. The antibody containing media was added to the wells containing hiPSC printed 
aggregates and incubated for 30 min in a laboratory incubator at 37.0 °C, 5.0% CO2. The medium 
was aspirated, and the wells were gently washed two times with cell culture medium. Fresh cell 













2.3.6 Automated Formation hiPSCs Aggregates 
Twenty-four hours prior to printing, 50μl of a 1:1 mixture of growth factor reduced Geltrex 
and differentiation supportive media (10% FBS, 1% ABAM, DMEM/F12) was added to 12 wells 
of a standard 96 well plate and stored in a laboratory incubator at 37.0 °C, 5.0% CO2. Before cell 
plotting, the plate was removed from the incubator and placed on the heated print bed (37.0 °C). 
Single cell suspensions of hiPSCs were obtained by rinsing hiPSC containing wells with DMEM, 
followed by a 5-min incubation with Accutase (Sigma-Aldrich). Cells were then centrifuged at 
300 x g for 3 min; the resulting pellet was diluted with differentiation-supportive media to a 
concentration of 4.5 × 106 cells per ml. These single cell suspensions of hiPSCs were then loaded 
into a pulled glass needle with a 40μm tip diameter at 10 μl min−1. The plotting routine was set to 
dispense a number of 100nl droplets 200μm (X, Y) apart and 250μm (Z) from the plate bottom into 
wells of a 96 well plate containing 50μl of a 1:1 mixture of growth factor reduced Geltrex and 
differentiation supportive media. Immediately following the plotting routine, the plate containing 
fabricated hiPSC aggregates was incubated at 37.0 °C, 5.0% CO2 for 7 days. 150 μl of 
differentiation supportive media was overlaid on the gel post-printing and changed every 24 hours 
for 7 days. Post-plotting, wells containing gel-embedded hiPSC aggregates were monitored using 
brightfield imaging every 30 min for 5 days using a Lumascope 620 microscope. 
2.3.7 Formation of hiPSC EBs Using Hanging Drop Method 
The hiPSC single cell suspension used in the automated plotting experiment was diluted to 
5 × 105 cells ml–1. 1 μl samples of the diluted hiPSC single cell suspension were then manually 
added to 20 μl of differentiation-supportive media which had been previously pipetted onto the 
inside surface of a Petri dish lid. The lid was then inverted to force cells to aggregate due to the 
effect of gravity. The dish bottom was filled with the same media to prevent drying and stored in 





2.3.8 Gene Expression Assay of Printed and Hanging Drop hiPSC Aggregates 
Total cellular RNA was isolated from 7 day old, 3D printed hiPSC aggregates and hanging 
drop hiPSC EBs with Trizol (Life-Technologies) according to manufacturer's protocol. RNA 
quantification was determined by UV absorbance at 260 nm (A260 nm) on a NanoDrop 2000 
(Thermo Scientific). 5 μg of each RNA sample was reverse transcribed into cDNA using the High-
Capacity cDNA Reverse Transcription Kit (Thermo Fisher) according to manufacturer's 
instructions. cDNA samples from established hiPSCs (control), printed hiPSCs and hanging drop 
EBs were amplified and detected using TaqMan Gene Expression Assays for markers, HAND1 
(Hs02330376_s1), SOX17 (Hs00751752_s1), PAX3 (Hs00240950_m1), NANOG 
(Hs04260366_g1), and the endogenous housekeeping gene ACTB (Hs99999903_m1). 
Quantitative Reverse Transcription PCR experiments were conducted with a StepOnePlus Real-
Time PCR System (Applied Biosystems). TaqMan Fast Advanced Master Mix was used in 
conjunction with TaqMan Gene Expression assays per manufacturer's protocol. All experimental 
reactions were completed in triplicate and the relative quantity was calculated using the 2−(ΔΔct) 
method. All statistical comparisons were made with ANOVA (*p < 0.01).
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Fig. 1.  CAD design and 3D printing of bioprinter modifications to the Felix 3.0. (a) CAD model 
of x-axis bioprinting adapter with lead screw and syringe adapter for injector depression. (b) 
Resultant 3D-printed bioprinter injector adaptor mounted to the X-axis of 3D printer with stepper 
motor installed for injector actuation. (c) CAD models for syringe adapter inserts for securing the 
body of the injector (bottom row) and clips for holding the plunger (top row). (d) Example of a 3D 
printed insert and clip used with the pulled glass-microcapillary pipette injector and teflon plunger. 
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2.4 Results 
2.4.1 Bioprinter Fabrication 
Most well-appointed commercial 3D bioprinters cost well above the budget limits of many 
biological laboratories wishing to use these tools for cell-based experimentation. To address this, 
we aimed to use readily available parts to adapt an 'off the shelf' extrusion-based, 3D printer into 
a high-precision, open-sourced bioprinter. The unmodified Felix has a positional resolution within 
a reasonable range for single cell deposition. We used CAD software to design a microextrusion 
apparatus to replace the plastic extruding print head, (Fig. 1a). These prototype parts were then 3D 
printed using the standard extrusion system on the unmodified Felix system, (Fig. 1b). To better 
serve our experimental requirements, the system was designed to be interchangeable with more 
than one type of plunger-driven syringe system (several sizes of luer-lock syringe, microcapillary 
pipettes, etc.), (Fig. 1c). Our 3D printed parts were highly accurate with regard to matching 
specified part dimensions (Fig. 1d). Furthermore, no measurable differences among printed 
components were observed confirming the Felix’s stated precision and accuracy. Additionally, we 
are not aware of any other current bioprinting systems that have the capability to be utilized as 
both a bioprinter and a standard 3D printing system. As such, this is the first report of a device 




Table 1:  Analytical solutions to CFD simulations of the bioprinting process using various microneedle 
geometries. Needle tips with a straight-sided, triangular appearance are labeled T. Needle tips with curved 
geometries are labeled C. Simulations were given conditions of steady, non-Newtonian flow of a constant mass 
flow of 6x10-5 kg/s. The inlet and exit diameter for all needle conditions equaled 1 mm and 60µm, respectively. 
The flow outlet boundary condition equaled standard atmospheric pressure, (101325 Pa). Numerical results 
indicated increasing needle length results in an increase in both total pressure and required force across all 
conditions. Results also indicated T needle types generate more internal pressure than C needle types of the 
same length. The average velocity for all T needle types was greater than C needle types. The maximum velocity 
was highest in the 1 mm long T needle type. Interestingly this needle type represents a 1:1 geometry near that 
of a straight-sided cone. 
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2.4.2 Needle Optimization Through Computational Modeling 
As we intended to use our 3D bioprinter to print liquids containing both biomolecules and 
sensitive cell types, we recognized the need to model various needle variants to determine the flow 
characteristics, including shear rates in the needle tip. To do this, we designed several permutations 
of needle types using 3D CAD software. The needle types of our initial simulations included a 
model of a conventional, syringe-needle system, and needles with various lengths and internal 
slopes with a straight-sided triangular, T, or parabolic curved, C, geometry. The straight triangular 
needle is characterized by having a linear change in needle diameter, whereas the curved needle 
types resemble more of a parabolic curve with a slope that is greater than one100. We then measured 
the impact of needle geometry on fluid dynamics during the bioprinting process using computer 
generated, multiphysics simulations. To provide a better understanding of needle clogging due to 
cell accretion, we traced particle streamlines of 10μm wide particles, the typical diameter of cells, 
through our needle models under conditions that favored aggregation. The aggregation of cells 
within the needle tip occurred by increasing particle accretion rates and lowering the normal and 
tangential coefficients of restitution at the needle wall. Particle studies then indicated a large 
population of cells with velocities near zero in the narrowest region of the conventional needle 
configuration, (Fig. 2a). These populations were not observed in triangular needle configurations, 
(Fig. 2b). This indicated the conventional needle type leads to a higher rate of cell aggregation and 
needle clogging when compared to a tapered, triangular needle. Furthermore, the results from the 
flow simulations also indicated cells traveling through the center of the conventional configuration 
have a higher velocity than those in the center of the straight triangular configuration, 75 mm s−1 
versus 55 mm s−1, respectively. 
The velocity profile established in a given flow situation strongly influences the mass 
transfer process. For our method of bioprinting, the mass transfer process is primarily dependent 
on the ability of the ejected droplet to remain inside the surrounding material. Furthermore, the 
needle tip should also impart minimal damage to the gel during the plotting procedures. Therefore, 
the best needle type should be narrow enough to penetrate the gel without disturbing surrounding 
material, limit unfavorable processing conditions for fragile cell types, and perform the printing 
process without clogging. To examine this concept a comparison between triangular, T, and 
curved, C, needles of increasing length was performed. The resulting data indicated all T type 
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needles have a higher average velocity than C type needles. Interestingly, we found the maximum 
velocity was greatest in the 1mm long needle type (Table 1). Yet, the 1 mm long T type requires 
lower force and results in a lower maximum pressure than both 7 mm long needle types. Given the 
inlet diameter for these simulations equaled 1 mm, the 1 mm long straight needle represents a 1:1 
geometry near that of a straight-sided cone. We also found conically shaped needles generate less 
internal pressure than straight-sided triangular needles of the same length. Numerical results 
indicate needle length has a significant effect on total pressure. Interestingly, the 7 mm C needle 
type, showed a sharp reduction in total pressure when compared to a straight-triangular needle type 
of the same length, 7 mm T. We found this relationship to suggest needle length and needle type 
has an effect on total pressure. While longer needle lengths resulted in higher total pressures, the 
C type needles were always lower in total pressure than the straight-triangular type of the same 
length. Overall, the results show that as the cross-sectional area of the microneedle decreases, the 
maximum fluid velocity increases and the pressure decrease.  
Results from our flow simulations also found the shear rate generated in conventional 
systems is greater than shear rates observed in needles with tapered geometries. These simulations 
suggest, as the extent and shape of the flow passages change, the cells within the fluids are 
subjected to stretching in one or more dimensions. It should be noted the shear rate in the 
conventional system was highest in the region immediately after the abrupt reduction in needle 
diameter, and also in the region nearest the needle tip, suggestive of elongational flow, (Fig. 3a). 
On the other hand, the shear rate observed in needles with a straight triangular taper is greatest in 
the region of the tip, (Fig. 3b). Furthermore, we were able to generate this post-constriction 
increase in shear rate in tapered needle types by increasing the length of the narrowest section of 
the needle (data not shown). 
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Fig. 2.  CFD particle studies of the bio-deposition process under conditions that favor 
aggregation. Heat map graphical representations of particle velocities of 10µm wide 
particles, the typical diameter of cells, traveling through idealized microneedle geometries 
representing: (a) conventional ‘luer-lock’ needle type and (b) triangular needle 
configurations under conditions of steady, non-Newtonian flow with a constant mass flow 
of 6x10-5 kg/s. The inlet and exit diameter for all needle conditions equaled 1 mm and 
60µm, respectively. The flow outlet boundary condition equaled standard atmospheric 
pressure (101325 Pa). Our model conditions accounted for the effects of gravity. The exit 
velocity for the conventional ‘luer-lock’ condition (a) was 72 mm/s, whereas the triangular 
needle (b) was 55 mm/s.  The aggregation of cells within the needle tip was encouraged by 
increasing particle accretion rates and lowering the normal and tangential coefficients of 
restitution at the needle wall. Under these conditions, particles near the exit of the 
microneedle with zero velocity (shown in blue) were only observed in the conventional 
‘luer-lock’ geometry types. 
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Using the results from our simulations, three microneedle geometry types were fabricated 
using a programmable pipette puller. The programmable pipette puller and our glass pipettes 
provided the ideal process to fabricate of many custom needle configurations. To provide a 
comparison to the standard 28-gauge stainless steel needle, these three types are shown in (Fig. 
3c). The three needle types shown in (Fig. 3c), from left to right, are examples of a 3 mm long 
straight-triangular needle with a 150μm tip diameter, a 5 mm long curved needle with 150μm 
diameter, and a 6 mm long curved needle with a 75μm diameter. One notable difference between 
the conventional needle and our pulled needles is the length of the narrow channel. 
The narrowest section of the conventional, stainless-steel needle is typically 30 mm long, 
which is five times longer than the typical length of our fabricated needles (~5 mm). Using needles 
with geometric features that minimize the amount of time cells travel through these narrow 
channels presents fewer opportunities for cells to aggregate, with a concurrent reduction in 
detrimental forces, both of which are a significant process improvement. Furthermore, by 
fabricating the needle from borosilicate glass tubes we were able to retain a high degree of 
structural rigidity without the need to increase the thickness of the needle wall. That is to say, the 
ratio of the outer-diameter to the inner-diameter is substantially lower for the glass needles than 
the conventional steel needle (Fig. 3c). This provided a substantial increase to the print resolution 
of our system. The conventional needle was not capable of the same degree of positional precision 
and repeatability as the glass needle. When compared to glass, the thin stainless-steel needle has 
more elastic material properties, which made it prone to bending during the printing process. The 
nonlinearity across the needle meant the needle tip was not always precisely above the target site. 
This also negatively impacted the plotting process by introducing insertion angles that were not 
always perpendicular to the target site, which resulted in increased disruption of the gelled material 




Fig. 3.  Shear Rate results from CFD particle studies of the bio-deposition process using 
various microneedle geometries. 10µm wide particles, the typical diameter of cells, 
traveling through idealized microneedle geometries representing: (a) Conventional ‘luer-
lock’ needle geometry, (b) triangular needle geometry under conditions of steady, non-
Newtonian flow with a constant mass flow of 6x10-5 kg/s. The inlet and exit diameter for 
all needle conditions equaled 1 mm and 60µm, respectively. The flow outlet boundary 
condition equaled standard atmospheric pressure (101325 Pa). Our model conditions 
accounted for the effects of gravity. Simulated results indicated cell sized particles travel 
through areas with greater amounts of shear in conventional ‘luer-lock’ needles than 
straight-sided triangular needles. (c) Examples of pulled-glass microcapillary tubes with 
tapered geometries (left to right): 3mm long straight-triangular needle with a 150µm tip 
diameter, 5 mm long curved needle with 150µm diameter, 6mm long curved needle with a 
75µm diameter, and 28-gauge stainless steel needle. 
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While we initially began our experimentation with a narrower 30-gauge needle, the high 
concentration of cells required for the printing process made printing through such long narrow 
needles unreliable due to frequent clogging. Through further experimentation, we found a 28-
gauge needle provided the required performance for our experiments. Despite the 25 μm increase 
in interior needle diameter than a 30-gauge needle, using 28-gauge needles did not completely 
alleviate the clogging issue. It should also be noted that the 28-gauge needle has an inner diameter 
four times larger than the pulled glass microneedles. Overall, borosilicate glass tubes which 
combine the needle and syringe into a single, rigid part with geometry optimized for fragile cell 
transfer are superior to conventional, stainless-steel needles. 
2.4.3 Cell Viability Assay 
To further study the effects of microneedle geometry on the dynamic process of 
bioprinting, we sought to determine if there was an appreciable real-world impact seen when 
applying the various needle permutations. To accomplish this we used an immortalized, non-
tumorigenic, adult MEC line, MCF-12A. Following injection into 96-well plates, the cells were 
assayed for metabolic activity 1 hour post-printing and then again 96 hours post-printing. Results 
from the AlamarBlue assay indicated a significant reduction in the number of viable cells 1 hour 
post-printing for the syringe 28-gauge needle condition compared to control (no-tip) for two 
printing speeds, 600 μl min−1, 1000 μl min−1 (Fig. 4a, *p < 0.05). This experimental data supports 
results from our simulations. A significant increase in viability was also observed 96 hour post-
printing for the 1000 μl min−1, straight-cone or triangular condition, compared to control, (Fig. 
4b, *p < 0.05). These data confirmed that while survival was comparable amongst many of our 
needle designs, when print speeds increase, a corresponding reduction in viability is observed in 
needles that were previously shown to have a greater shear rate. This is likely due to the initial 








Fig. 4.  MCF-12A Alamar Blue cell viability studies post-printing. (a) Alamar Blue 
reduction 1 hour post-printing (*p < 0.05), (b) Alamar blue reduction 96 hours post-
printing (*p < 0.05). MCF-12A cells were suspended in media to a concentration of 1 x 
106 cells/ml. For all conditions, approximately 25µl of media was loaded into the needle 
at a rate of 10µl/min and dispensed into wells of a 96 well plate at one of four rates: 100, 
400, 600, and 1000µl/min. All four rates were repeated in three separate wells for a total 
of 12 wells per condition. Four needle conditions; no-tip (control), 27-gauge needle, 
straight cone, and long tapered needle were tested, giving a total of 48 wells. The sample 
mean viability was calculated and normalized to the initial viability of the no-tip control. 
Statistical significance was determined using one-way ANOVA with Dunnett’s post hoc 
test (*p < 0.05). Error bars, mean ± s.d. 
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2.4.4 Print Resolution Verification 
As the diameter of most somatic human cells are between 10–30 μm, and the spacing 
between injection points is largely determined by the diameter of the needle, we wished to generate 
a system capable of printing as close to this target range as possible. Precise placement of different 
cell types or signaling molecules and other various components in as close proximity to a 'cellular' 
resolution would be highly advantageous. To test the limits of printed cell resolution and the 
possibility of obtaining single cell extrusion events, we injected 1nl of media containing GFP 
labeled MDA-MB-468 cells into ~1 mm thick Geltrex, (Fig. 5a). To provide better illustration of 
this process, (Fig. 5b-d) represent GFP, bright-field, and combined channels of the single cell 
'events' our system generates. Analysis of the single-cell extrusion events indicated our system is 
capable of reliably extruding single cells. To further examine the capacity of our printer, we 
quantified the distances among printed cell locations using ImageJ software to define positional 
precision. This analysis found the X and Y resolution to be ±6.34μm and ±9.71 μm, respectively, 
confirming the factory-listed resolutions (13μm × 13μm (±6.5μm)). In addition to positional 
precision, bioprinting techniques also require precise control over the amount of extruded material. 
To determine how effective our printer was at controlling the amount of extruded materials, 
we generated a gradient of GFP labeled rat epithelial cells by decreasing the extrusion amount in 
each successive row from 70nl, 60nl, 50nl and 10nl, (Fig. 5e). Upon manual counting, the number 
of cells within each print location, from top to bottom, averaged 68 ± 6, 62 ± 4, 51 ± 4, and 8 ± 2, 
respectively. The theoretical cell concentration in the media used to generate the gradient study in 
(Fig. 5c) represented a distribution of 1 cell per nl. Given this information, we observed an overall 
congruency among the number of counted cells and the directed extrusion amount. The variation 
in the number of printed cells was greatest in row one, the group with the largest extrusion amount. 
We expected to observe greater variation in the number of cells in the larger extrusion conditions 
because our approach is largely based on pairing the probability of a single cell within a specified 
extrusion amount. The duration of the plotting procedure was less than 3 min. Therefore, it appears 
printing within this time window prevents confounding variables such as cell settling due to 
gravity. The results in Fig. 5 provide information on the ability of the system to repeatedly handle 
volumes from 1 to 100nl. Furthermore, they provide insight into our systems ability to repeatedly 







Fig. 5.  Printer resolution and functional limitations. (a) 1nl extrusion, each containing a 
single GFP labeled MDA-MD-468 cell printed into ~ 1mm thick Geltrex. Scale bar 100µm. 
(b) GFP channel of single-cell extrusion event using MDA-MD-468 cells. Scale bar 
100µm. (c) Bright-field channel of the same single-cell extrusion event. Scale bar 100µm. 
(d) Combined GFP and bright-field. Scale bar 100µm. (e) Decreasing gradient of GFP 
labeled rat epithelial cells generated by extruding 70µL, 60µL, 50µL, and 10nL. Scale bar 
300µm. 
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2.4.5 Bioprinted hiPSCs 
Bioprinting pluripotent cells to generate biomimetic embryonal structures is a crucial step 
for disease modeling and tissue engineering. However, the printing process can physically alter 
the cellular structure resulting in unwanted shifts in gene expression and protein function. Having 
previously determined our extrusion system has minimal shear and pressure related effects on 
cells, we hypothesized that our system would have no negative impact on hiPSCs printed into 
either differentiation or pluripotent-conducive environments. We first wanted to determine if our 
system was capable of printing hiPSCs that retain their pluripotency post-printing. To test this, we 
used our pulled glass needles to print 3D aggregates of hiPSCs using pluripotency-conducive E8 
media into growth factor reduced Geltrex. Following 7 days post-printing of the iPSCs we then 
stained the aggregates with pluripotency antibody TRA-1-81, a cell surface marker specific for 
pluripotent cells (Fig. 6a), confirming that our system does not alter the ability of iPSCs to retain 
a pluripotent state. 
We next wanted to test the ability of our system to generate differentiated EBs. To confirm 
the differentiation of our injected hiPSCs, we compared their gene expression changes to the gold-
standard hanging-drop EB method. We therefore printed hiPSC in Geltrex (500 cells per injection) 
with FBS containing media and in tandem deposited hiPSCs on culture flask lids (500 cells per 
droplet) and following lid inversion, allowed them to incubate at 5% CO2, 37 °C for 7 days. To 
then evaluate and confirm that the differentiated EBs were similar in nature, mRNA was extracted, 
and qRT-PCR was performed. The results of our gene expression assays indicated a significant 
up-regulation of differentiation markers for the endoderm (Sox17), mesoderm (Hand1), and 
ectodermal (PAX3) lineages in the printed hiPSC group as compared to non-printed, non-
differentiated control hiPSCs, (Fig. 6c), *p < 0.01). Interestingly, the gene expression was also 
significantly upregulated as compared to the hanging drop EBs, possibly indicating a more mature 
differentiation. To observe the motility and growth of our injected hiPSCs we followed the 
injections with time-lapse imaging. This revealed the initial formation of spheroids followed by 
the dynamic growth of secondary and tertiary structures similar to budding, elongation, and 
increased complexity over 7 days, (Fig. 6d, & Sup. Movie 2.1-2.3). 
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Fig. 6.  3D printed hiPSCs. (a) Presence of green fluorescence due to TRA-1-81 binding to 
undifferentiated pluripotent cells in 3D printed hiPSC aggregate 7 days post-printing. Scale 
bar 50µm. (b) Bright-field image of 3D printed hiPSC aggregate. (c) Gene expression 
profiles of hiPSCs using markers for ectoderm (Pax 3), mesoderm (Hand 1), endoderm (Sox-
17), and pluripotent marker (Nanog) (*p < 0.01). Error bars, mean ± s.d. (d) 7 day-time lapse 
images of bioprinted hiPSCs in a 1:1 mixture of Geltrex/differentiation supportive media 
reveal dynamic growth and increased complexity (left to right, top-left taken at t0). 
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2.5 Discussion 
Using 3D printed parts and highly accessible hardware, we were able to reliably print at 
precise XYZ locations within 3D hydrogels cellular aggregates in various concentrations with 
injection volumes ranging from 1nl to hundreds of microliters with spatial resolution only limited 
by the diameter of the needle itself. Currently, our system can obtain prints containing 1 cell per 
injection event. We attribute part of this cellular resolution to the use of stepper motors, which are 
ideally suited for extrusion-based bioprinting as they offer a unique solution for open-loop position 
control. Specifically, the output shaft rotates in a series of discrete angular intervals, or steps, each 
time a command pulse is received, therefore the exact displacement of the shaft is known. This 
feedback allows the user to modify the acceleration rates and deceleration rates of the fluid while 
traveling through the needle during 3D printing experiments. This forward/reverse positional 
control gives an additional level of process control unseen in solenoid valve-based systems that 
have been previously examined90,93. Additionally, the shaft of the motor will remain at a specific 
step until another step pulse is supplied, which provides exceptional positional control and 
eliminates leaks from the needle tip. 
It is known that the fluid characteristics during syringe needle flow introduce three main 
types of mechanical forces capable of cell disruption: (i) shearing forces due to linear shear flow, 
(ii) pressure drop across the cell, and (iii) stretching forces due to extensional flow66. Numerous 
studies have implemented novel hydrogel-vehicle systems as a sacrificial, viscoelastic material to 
encapsulate cells and alter the distribution of damaging mechanical forces experienced during 
flow66,97,101,102. Yet, despite encapsulation in alginate solution (1.5% w/v), one study found ink-jet 
dispensing pressure demonstrated a more significant effect on cell viability than nozzle diameter; 
constructs printed at 40 psi showed a 38.75 % reduction in viability compared to those printed at 
5 psi103. Recently, Faulkner-Jones et al found an effect of nozzle length and dispensing pressure 
on human pluripotent stem cell viability; cells printed through an 8.9mm long nozzle showed 
higher levels of viability than those in a 24.4mm long nozzle93. We therefore tested if injection 
systems which impart the lowest amount of overall shear would be preferable for fragile cell 
transfer; and if those systems which minimize the amount of time a cell flows through the highest 
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shear-rate section of the needle (or nozzle) would be preferable to systems in which the cells spend 
a greater amount of time flowing through high shear-rate sections. 
To investigate this, we compared the force distribution of several needle types using FEM 
to identify features related to cell damaging forces. This approach enabled us to examine the 
development of these forces throughout the bioprinting process using systems of equations that 
included boundary conditions with slip along the needle wall. Mathematical models have been 
developed which indicate tapered needle geometries result in different cell damages due to the 
conical geometry and changing force distribution in the needle100. Billiet et al. found a significant 
pressure and needle type dependence on cell viability; at low inlet pressure, conically shaped 
needles are preferred over cylindrically shaped ones104. However, they found this advantage 
disappears at higher inlet pressures, yet they did not vary the length of the needle or the angle of 
the needle tip in their studies. Our investigation found short, conically shaped needles are preferred 
over long cylindrically shaped geometries due to a favorable axial pressure gradient that requires 
less energy to accelerate fluid through the microneedle, and a substantial reduction in the amount 
of shear in the needle tip. When the cross-section of a pipe gradually narrows, such as the straight-
triangular needle in (Fig. 3b), the streamlines follow closely along the contours of the pipe and 
virtually no extra frictional losses are observed. By generating a more even transition to the narrow 
diameter needle tip, tapered needles provide a better-suited environment for fragile cell transfer. 
Furthermore, when this transition is abrupt, such as those of the conventional 'luer-lock' 
configurations, the inner diameter of the syringe is notably larger than the needle tip, and the cells 
undergo a correspondingly abrupt increase in linear velocity as they pass into the needle, also 
known as extensional flow. This convergence to a small point, coupled with the increased shear 
seen in the long, cylindrical needle appear to be the two components that contribute to unfavorable 
printing conditions related to fragile cell transfer. With these hypothetical variations in mind, we 
confirmed that syringe-needle extrusion rates greater than 600 μl min−1 influence cell viability 
when compared to no-tip controls. Additionally, when examining the 96-h post injection viability 
it was clear that extrusion velocity and the needle geometry had a significant effect on growth. 
3D based organogenesis from hiPSCs is one of the most exciting areas of tissue engineering 
and biofabrication. The approach of self-organizing pluripotent cells into functional differentiated 
cells not only represents a better model of natural processes, but also serves as a highly efficient 
method of organogenesis. Our investigation provides essential information on how biofabrication 
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parameters such as needle geometry and flow rates may affect the post-printing behavior of 
hiPSCs. Positive TRA-1-81 staining of hiPSC printed aggregates in pluripotent supportive 
environments, indicated our printing device was capable of delivering unaltered pluripotent cells 
into 3D environments without the need for protective encapsulation strategies. Furthermore, when 
these same pluripotent cells were injected into differentiation signaling environments, the printed 
hiPSC aggregates generated small, spherical clusters of cells that then began to depart from the 
main body and wander through the 3D matrix. Interestingly the gene expression analysis revealed 
a significant increase in differentiation and pluripotent markers as compared to both the non-
differentiated iPSC and the standard EB formation methods. It is known that the physical features 
of the surrounding structure affect the differentiation of stem cells, therefore, one way to explain 
the increase in relative expression of these genes in the printed group, when compared to the non-
printed control, may be due to an interaction among the hiPSCs and 3D gel-matrix. Instead of 
directly mixing these highly sensitive cell types with the scaffold materials required to generate 
3D structures, our approach sought to prevent these types of cell-structure interactions by placing 
cells into specific 3D locations inside a pre-formed, 3D architecture. Because these cells are not 
directly included in the fabrication process, which often requires the structural change of the 
scaffold from a liquid to a gel post-printing, this method attempts to eliminate these types of 
extraneous variables to better understand the differentiation pathways that iPSCs follow when 
placed in a 3D environment. This feature could expose many future advantages that would 
establish a better understanding of normal tissue and organ development. This holds many benefits 
for developing models that better mimic human disease as well as affording us the capability to 
design and construct accurate replacement cellular constructs. 
Here, we have described a simple process for development of an accessible and high 
precision 3D bioprinter through modification of an inexpensive 'off the shelf' 3D printer. The 
bioprinter uses a pulled-glass capillary pipette to minimize shear stress and optimize positional 
control and precision. This minimal cellular impact enabled our system to successfully print 
hiPSCs while maintaining their pluripotency. Additionally, we were able to print hiPSCs into 
differentiation-conducive environments that generated cells of all three developmental germ-
layers. To the best of our knowledge, our system is the first 3D printed, bioprinting system to 
reliably achieve single cell print resolutions within 50μm resolution, while also exerting minimal 
unwanted impact on the cells viability and post-printing fate. Furthermore, our system is highly 
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modifiable and can be fabricated for use on any 3D printer. This type of system is ideal for 
adaptation by both basic and clinical research laboratories for the study of cellular interactions 
and/or tissue engineering applications.  
We would like to note that our bioprinting system upgrade cost less than $200 (not 
including the off-the-shelf printer, which could be substituted for other models). Our hope is our 
system, or similar systems will lower the technical and financial hurdle of 3D bioprinting to any 
laboratory with an interest in furthering the developments of 3D cellular biology. As open-sourced 
projects have developed advanced software systems such as Unix, and hardware solutions such as 
Arduino and Raspberry Pi, here we institute similar initiatives within the field of biofabrication. 
Overall, these results indicate we successfully achieved our first objective of designing and 
manufacturing an accessible, 3D bioprinting device capable of reliably printing cell aggregates 
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3D BIOPRINTING MAMMARY EPITHELIAL ORGANOIDS 
3.1 Overview 
While capable of generating high-throughput experimental designs to answer today’s ‘big 
data’ biological questions, bioprinting technology has remained inaccessible to most research labs 
due to the uncertainty as to whether the research benefits will outweigh the operational cost. In 
this study, we set out to incorporate our bioprinting technology into 3D cultures of human MECs. 
First, we hypothesize that MEC organoid formation is determined and regulated by the amount of 
local cell-cell interactions. To test this, attention was given to the ability to control the amount of 
‘bio-ink’ deposited in a specified location to promote MEC ‘self-assembly’ into cell-organoid 
structures. Second, it was hypothesized that the orientation of in vitro mammary organoid 
formation is determined by neighboring cell activity that imparts directional cues during the initial 
stages of MEC cell-organoid structure formation. This hypothesis was tested by determining the 
spatial distribution required to direct individual organoids to undergo coordinated, organoid fusion 
events along the entire length of the bioprinted array. Finally, this chapter concludes with a review 
of current work to develop and employ new methods to incorporate additional ‘bio-inks,’ cell 
types, and other biologically active materials into 3D cultures. 
 Standard 3D in vitro culture techniques, such as those used for MECs, rely on random 
distribution of cells through hydrogels. While these systems offer advantages over traditional 2D 
models, limitations persist owing to the lack of control over cellular placement within the hydrogel.  
This results in experimental inconsistencies and random organoid morphology. Robust, high-
throughput experimentation requires greater standardization of 3D epithelial culture techniques. 
Here, I detail the use of a 3D bioprinting platform as an investigative tool to control the 3D-
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formation of organoids, through the ‘self-assembly’ of human MECs. Experimental bioprinting 
procedures were optimized to enable the formation of controlled arrays of individual mammary 
organoids. I define the distance and cell number parameters necessary to print individual organoids 
that do not interact between print locations, as well as those required to generate large, contiguous 
organoids connected through multiple print locations.  Results indicate that as few as 10 cells can 
be used to form 3D MEC structures in a single print location. Furthermore, spacing print locations 
up to 500µm apart can be used to guide the development of large organoids with directed shapes 
and sizes. Using these fusion parameters, both linear and non-linear (contiguous circles) can be 
generated with sizes based on the available material inside the culture area. Results confirm cells 
from individual print locations interact to form structures with a contiguous lumen. This platform 
is adaptable to different culturing protocols and is superior to traditional, random 3D culture 
techniques in efficiency, reproducibility, and scalability. Importantly, due to the low-cost 
accessibility and CNC driven processes of our 3D bioprinter, we have the ability to disseminate 
our experiments with absolute precision to interested laboratories. 
3.2 Introduction 
3D culture systems for generating organoid cultures of MECs inside collagen matrices 
were first introduced over four decades ago33. In 3D culture, multiple parameters operate together 
to affect both experimental outcomes and interpretation of experimental results. These parameters 
include cell type, cell-cell interactions, ECM composition, culture media, and mechanical 
properties such as matrix stiffness and cell confinement40-50. Standard 3D culture procedures 
involve either mixing dispersed mammary epithelial cells within ECM substrates prior to gelling, 
or by culturing cells on top of a pre-formed ECM gel. Once polymerized, the ECM gel can be left 
attached to the culture dish or floated. The encapsulated cells will then randomly organize into 
organoids which remodel and reorganize the substrate matrix to generate structures composed of 
morphologically polarized cells facing an open lumen31,34,36-39. However, the size and morphology 
of resulting organoids varies greatly, even within the same ECM gel substrate. While some 
variability inevitably results from disparities in local environmental conditions, such as collagen 
fiber anisotropy within specific regions of a gel, a major source of potentially controllable 
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variability results from the random distribution of cells within the gel57,59,61,62,105,106. This 
variability leads to difficulty in interpreting and reproducing results, especially laboratory to 
laboratory. As inter-laboratory reproducibility is a major concern in modern biomedical research, 
platforms that will allow for better control and reproduction of results are highly desired107. 
We have recently described the adaptation of an off the shelf 3D printer for the purposes 
of bioprinting cells in 3D substrates108. Our goal was to design an accessible, open-access 
bioprinter that would not be cost prohibitive to research laboratories. Because of the precision 
afforded by the CNC system, and the ability to share the G-CODE underlying the printing process, 
the use of bioprinting in basic research laboratories offers promise for new standards designed to 
increase internal and intra-laboratory experimental reproducibility. Specifically, the use of CNC 
systems to control the spatial deposition of cells in 3D structures appears well suited to recreate 
the tissue-specific, contextual cues needed to overcome the limitations of manual pipette-
patterning108,109. Here, I describe the adaptation and validation of an accessible bioprinter to 
produce high-fidelity, spatially-controlled arrays of human mammary organoids inside 3D 
collagen matrices. We demonstrate the superiority of our printing process over manual matrix 
embedding techniques in efficiency and consistency in organoid morphology. We further describe 
parameters necessary to generate large organoids with shapes dictated by print locations (e.g. linear 
or circular). These data lay the groundwork for adapting 3D bioprinting methods using additional 
cell types and 3D matrices, thereby providing an ideal method to derive empirical standards aimed 











3.3 Materials and Methods 
3.3.1 Cell Culture 
Immortalized non-tumorigenic human breast epithelial cell line, MCF-12A was purchased 
from ATCC. MCF-12A cells were initially cultured in 2D on tissue culture plastic in a 75 cm2 
flask supplemented with a 1:1 mixture of Dulbecco’s modified Eagle’s medium and Ham’s F12 
medium (DMEM/F12), 5% Horse Serum, 20 ng ml-1 hEGF, 0.01 mg ml-1 bovine insulin, 500 ng 
ml-1 hydrocortisone and 1% ABAM (ThermoFisher). MCF-12A cells were cultured at 37.0 °C and 
5.0% CO2. After confluence, the cells were dissociated using TrypleE (ThermoFisher) and 
collected by centrifugation. 
3.3.2 Preparation of Collagen ECMs and Manual Cell-Matrix Embedding 
For manual cell-matrix embedding studies, single cell suspensions of MCF-12A cells were 
mixed with neutralizing solution and acidified rat tail collagen I (Corning) as specified by the 
manufacture, unless noted otherwise, to a final concentration of 1.5 mg/ml. Immediately after 
mixing, 500µl of neutralized collagen I gel material, containing approximately 5000 cells, was 
dispensed into a 24 well plate and allowed to solidify and adhere to the surfaces of the well for 1 
hour in a laboratory incubator at 37.0°C and 5.0% CO2. After gelation (solidification), 500µl of 
cell media was added to the wells. Subsequent media changes were performed every 3 days. 
VitroCol, human collagen I solution (Advanced BioMatrix), was prepared according to 
manufacturer’s recommendation to a final concentration of 1.0 mg/ml. For all printing 
experiments, a minimum of 500µl of collagen gel was dispensed into individual wells of a 24 well 
plate and allowed to solidify for 1 hour in a laboratory incubator at 37.0°C and 5.0% CO2. For all 
experiments, cells were monitored using a combination of brightfield imaging/fluorescent imaging 





3.3.3 Bioprinting System 
A previously developed bioprinting system was used to robotically insert a microneedle 
into specified 3D locations of a polymerized collagen gel108. Immediately before printing, 2D 
cultures of MCF-12A cells were dissociated into single cells using TrypleE (ThermoFisher), 
centrifuged at 300×g, and re-suspended in media to obtain a final ‘ink’ concentration of 60×104 
cells ml-1. Shortly thereafter, 50µl of cell-containing ‘ink’ was loaded into a sterile needle. Printing 
operations were initiated after the ‘ink’ containing needle was attached to the print head. The 
number of cells deposited in a target location was manipulated by varying the volume of cell-
containing ‘bio-ink’ extruded from the needle tip, or to equalize volumes, by increasing or 
decreasing initial cell concentration. Printing operations were optimized to extrude specified 
numbers of cells inside the collagen I gel via a CNC insertion routine which deposited cell 
containing media at a specified ‘target’ location inside the polymerized collagen I gel. Users 
specified intended wells of commercially available tissue culture plates, printing locations, 
distances among printing locations, and the number of cells per target location. The experiment 
information was automatically converted into G-code, loaded into Repetier Host, and sent to the 
three-axis microcontroller of the bioprinter. The bioprinting system was located inside a benchtop 
biosafety cabinet during all printing operations. The heated print bed was set to 37° for all printing 
operations. Needles used by the bioprinting device were fabricated using a Sutter P97 
programmable pipette puller to have tip diameters of 50µm. All printing equipment was sterilized 
using steam autoclave prior to printing procedures. After printing routines were complete, plates 
were covered with 500µl of media and placed inside a laboratory incubator at 37°C, 5% CO2. Post-
printing, cells were monitored using a combination of brightfield imaging/fluorescent imaging 
using a Zeiss axio-observer Z1 fluorescent microscope, or time-lapse imaging using a Lumascope 
620 microscope. Cell-specific media exchange was performed every 3 days. All experimental 
conditions were performed in triplicate. 
3.3.4 Characterization of Organoid Growth and Morphology 
Immediately after printing, the initial quantity of printed cells was verified using manual 
counting and image analysis using ImageJ and Matlab. Post-printing, cells were monitored up to 
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21 days using a Zeiss axio-observer Z1 fluorescent microscope. The size of organoids was 
determined by analyzing bright-field images taken daily for each experimental condition using 
ImageJ. Within this investigation, organoids were operationally defined as a cluster of cells with 
no clear cell-cell boundaries, or the inability to discern individual cells from neighboring cells. 
 3.3.5 Immunofluorescence Staining 
Gels were fixed in 10% neutral buffered formalin, paraffin embedded and sectioned.  
Sections were prepared for staining by deparaffinizing in a xylene substitute, rehydration, and 
heat-mediated antigen retrieval using pH 9 tris-EDTA with 0.05% tween 20. Sections were 
blocked in 10% goat serum and incubated with primary antibodies in a humidified chamber at 4°C 
overnight. Secondary antibodies were added for 1 hour at room temperature. Sections were 
counterstained with DAPI. Antibodies were used at the following concentrations: mouse 
monoclonal antibody to BetaCatenin [12F7] (1:50; ab22656, Abcam), anti-green fluorescent 
protein rabbit IgG Alexafluor 488 conjugated (1:75; Invitrogen A21311); rabbit monoclonal 
antibody to cytokeratin 5 [EP1601Y] (1:75; ab52635, Abcam), mouse monoclonal antibody to 
cytokeratin 8 [C-51] (1:35; ab2531, Abcam), rabbit anti-pan-cadherin (1:75; 71-7100, 
ThermoFisher), rabbit polyclonal antibody to GJB6 [Cx30] (1:25;  HPA014846, Sigma-Aldrich), 
and rabbit polyclonal antibody to GJB1 [Cx32] (1:25; HPA010663, Sigma-Aldrich). Appropriate 
Alexafluor 488 and 568 conjugated goat antibodies (1:1000; ThermoFisher) were used for 
secondary antibody labeling. All sections were counterstained with DAPI and imaged using a Zeiss 
axio-observer Z1 fluorescent microscope. 
3.3.6 Statistical Analysis 
 Statistical analyses were performed using the software GraphPad Prism. Results were 
assessed for statistical significance using Student’s t test. Differences were considered statistically 
significant at *p < 0.05. 
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3.4 Results 
3.4.1 Manual Matrix Embedding Culture Technique 
As the main aim of this work was to validate experimental bioprinting methods for 
investigating mammary epithelial biology in 3D culture, we first established baseline behaviors of 
MCF-12A cells using manual cell-matrix embedding techniques. Furthermore, to determine the 
effect of physical parameters on MEC behaviors in 3D cultures, we compared the growth patterns 
of MCF-12A organoid formation in attached and floating 3D collagen I gels. Similar to previous 
findings 61,110, these results found an extremely high level of inter and intra experimental 
variability. 
Heuristically speaking, organoid growth patterns during the first 5 days under these two 
conditions were similar. Day 1 following the manual embedding of cells within collagen gels, the 
cells were similar in morphology, with cells either remaining dispersed individually or forming 
small clusters (Fig. 7a,b). This activity seemed to correspond with the random nature in which the 
cells were embedded in the gel—i.e. the distance among cells in the 3D matrix.  
In both conditions, noticeable structures emerge by day 5 (Fig. 7a,b). However, by day 8 
the attached and floating conditions resulted in prominent structural variations, which, by day 14, 
presented distinguishable organoid morphologies (Fig. 7a,b). An average organoid size of (509 ± 
169µm) and (302 ± 114µm) were obtained after 14 days of culture in attached and floating collagen 
I gels, respectively. Overall, three common organoid morphologies were observed: sphere like 




Fig.7.  Manual method of MCF-12A Organoid Formation. Example of random organoid 
dispersion and morphology of MCF-12A cells following manual matrix embedding in 
collagen gels either (a) attached to the culture plate or (b) floating, at 5, 8, 10, and 14 days 
(left to right). Scale bar: 200µm. (c) Single phenotypic organoid observed in attached gels.  
Scale bar 50µm. (d) Organoid linking multiple organoids in floating gels. Scale bar 50µm. 
(e) Image showing organoid with protrusions extending into floating gel. Scale bar 100µm. 
(f) Additional organoid type found only in floating gel. Scale bar 100µm. 
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Interestingly, MCF-12A organoids in attached gels only formed hollow, single-cell thick, 
‘sphere-like’ organoids ranging from 190-1235µm in diameter (Fig. 7a,c). However, the ‘sphere-
like’ organoids in floating gels ranged from 100-618µm, displayed more complex morphologies, 
and contained a dark, inner cell-mass (Fig. 1d). Additionally, the cell structures produced in 
attached gels continue to grow into the boundaries of neighboring structures (Fig. 7a). In addition 
to the presence of organoid phenotypes not observed in the attached condition, floating collagen 
gel cultures resulted in networked arrays of organoid structures. (Fig. 7b). It appears that the ‘duct-
like’ organoid phenotype is associated with directional growth patterns, which form networked 
structures among the ‘sphere-like’ acini (Fig. 7e). These ‘duct-like’ organoids were frequently 
preceded by and associated with cells exhibiting elongated morphologies with visible processes, 
likely demonstrating cell-matrix interactions (Fig. 7f). In agreement with previous reports62,  these 
results indicated the floating collagen gels underwent gel shrinkage of several millimeters 
throughout the culture period. 
Within 14 days in a standard 24 well plate, the initial mixtures of 5000 cells/well resulted 
in average of (439 ± 59) and (1060 ± 209) organoids/well for attached and floating conditions, 
respectively.  Thus, attached gels require an average of 11.39 cells per organoid, whereas floating 
gels required about 4.72 cells per organoid. As can be seen from the images in (Fig. 7a,b), the 
matrix embedding technique resulted in random organoid distributions for both culture conditions, 
which further illustrates the difficulty in interpreting experimental findings using traditional 
embedding techniques. However, statistical analysis of experimental data indicated the effect of 
culture conditions was significant (*p < 0.001, two-tailed). These data support the idea that the 
increased rigidity of the culture environment has a negative effect on the ability of breast epithelial 
cells to form organoids. This implies that a biophysical component is involved in regulating breast 
epithelial differentiation. This observation is noteworthy because women with dense breast tissue 





Fig. 8.  Design of the 3D bioprinting platform. (a) Adapted 
commercially available 3D printer. (b) Example of machine path 
during insertion routine. (c) Pulled-glass microneedle. Scale bar 
1mm. (d) 24 well plate containing 3D bioprinted mammary 
epithelial organoids 14 days post-printing. (e) Bioprinted MCF-
12A organoids 7 days post-printing. Scale bar 500µm. 
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3.4.2 Generation of Consistent Individual Mammary Epithelial Organoids 
Using this baseline as our comparator, we next sought to identify the core parameters to 
reliably generate and guide the formation of organoids using our low-cost bioprinting system (Fig. 
8a)108. Our bioprinting method uses CNC processes to guide microneedles to directly insert cells 
into 3D locations of polymerized collagen I gels (Fig. 8b,c). Importantly, previous studies have 
established that multiple needle insertions into a polymerized collagen gel did not disrupt 
neighboring cell-deposits108. This bioprinting technique eliminated the random cell distribution 
commonly observed in layer-by-layer processes and manual cell-matrix embedding procedures by 
confining cell aggregates in specified locations (Fig. 8d,e).  
We initially assessed if the formation frequency of individual human mammary epithelial 
organoids could be increased by controlling the initial number of singly-dissociated cells in a 
specified location. Using our bioprinting device, we dispensed cell-laden media at equivalent 
volumes in equally spaced, linear arrays inside collagen I gels and tracked them daily for 14 days 
(Fig. 9). Results indicated initial cell injections of ≤ 5 cells formed individual organoids at 
frequency of 1/50 and 28/50 at 7 and 14 days, respectively. However, when the initial printed cell 
number equaled 10 cells, our system achieved 37/50 and 49/50 organoid efficiency at 7 and 14 
days, respectively. Using 40 and 60 cells resulted in consistent (50/50) organoid formation for both 
7 and 14 days. These results indicate reliable generation of individual organoids can be achieved 
by increasing the initial number of cells (≥10) in specified locations with a spacing of 500µm. We 
also found printed cell clusters containing cell numbers (≥10) cells consistently develop branched 
processes, exclusively pointed towards neighboring organoids, which, by day 10, had formed a 
contiguous structure (Fig. 9). Furthermore, the temporal nature of this branching process increased 
correlative to the addition of more cells within the initial printing event. These results suggest 





Fig. 9.  Bioprinting results in consistent organoid formation. MCF-12A cells were printed 
at 500µm between print locations using initial cell concentration of 5, 10, 40, or 60 cells 
(columns, left to right, respectively). Images were taken at Days 4, 5, 6, 7, 9, 10, 12 and 14 
(rows top to bottom, respectively). Initial injections of 10 or more cells resulted in 
consistent organoid formation. Consistent fusion of multiple print locations was seen by 














Fig. 10.  Organoid fusion occurs between organoids printed up to 500µm apart. 
MCF-12A cells were printed (40 cells per deposit) at distances of 500µm, 400µm, 
300µm, and 200µm (columns, left to right, respectively). Consistent fusion was 
seen by day 11 in all cases, with contiguous organoids forming between prints 
spaced ≤ 400µm apart. Scale bar 500µm. 
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3.4.3 Directing the Generation of Large, Contiguous, Mammary Epithelial Organoids 
As the consistent nature of individual organoid formation changed with the variation of 
cell number, we next sought to determine if varying the inter-organoid distances could evoke a 
similar impact on the bridged-contiguous organoid formation that we observed in our linear arrays. 
To this end, we monitored the effect of organoid spacing on growth behavior by printing MCF-
12A cells along linear arrays of cell-deposits containing 40 (± 6) cells in collagen gels (Fig. 10). 
Data indicated inter-organoid spacing (≤300µm) directed collective cell growth of all (36/36) 
organoids into duct-like patterns along the entire length of the linear array (~4mm) within 7 days 
post-printing (Fig. 10). At 400µm, 34/36 organoids fused within 7 days post-printing (Fig. 10). 
Twenty-three of the 36 organoids spaced 500µm apart achieved organoid fusion within 7 days, 
however, 35/36 of these organoids achieved fusion by day 11 (Fig. 10).   
Closer examination of the 500µm print conditions indicated cell numbers increased during 
the first 3 days post-printing (Fig. 11a). Between day 3 and day 5, MCF-12A cell clusters began 
to form branched extensions, radiating from the initial print location (Fig. 11b). By day 7, these 
extensions matured and formed connections among neighboring organoids (Fig, 11c). Time-lapse 
imaging confirmed the branched extensions were directed toward neighboring organoids (Sup. 
Movie 3.1). Time-lapse imaging data also indicated global MCF-12A cell migration appears to 
follow the routes established by these initial extensions (Sup. Movie 3.2). It was noted that 
decreasing organoid spacing appears to promote the initial formation of a central structure 











Thus, by manipulating the spacing we can predictably increase the formation of a 
contiguous structure. Of note was the propensity of individual organoids to maintain the prescribed 
nature of the initial printed pattern throughout this fusion process. However, the importance of 
spacing distance on the degree of inter-organoid interactions was particularly highlighted when 
neighboring linear arrays printed ≥700µm apart failed to achieve robust interaction (data not 
shown). We believe these results provide substantial evidence of the superior ability of 3D 
bioprinting platforms to direct and control the formation of MEC organoids than manual matrix 
embedding methods. 
 
Fig. 11.  Maturation and formation of MCF-12A organoids. 
Images of bioprinted, MCF-12A cell-deposits at 500µm 
spacing (a) 3 days post-printing, (b) 5 days post-printing, (c) 
7 days post-printing. Scale bar 200µm. 
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3.4.4 Generating Additional Shapes Through 3D Bioprinting 
Next, we examined the possibility of directing contiguous luminal structures to conform to 
alternative shapes. We printed 40 cell clusters in a radial pattern in rat tail collagen gels with 
spacing patterns similar to our linear arrays at 500µm, 400µm, and 300µm (Fig. 12a). After 7 days, 
all of the print locations had formed individual organoids (Fig. 12a), and obvious processes and 
connections were actively forming among the 300µm spaced injections (Fig. 12a). By day 7, 
similar again to our linear arrays, all groups with at least 30 cells formed contiguous structures, 
which reflected the intended circular geometry (Fig. 12b,c). Furthermore, our ability to direct MEC 
structures was maintained throughout 24 days of culture, wherein the cells reacted similarly to the 
linear arrays by maintaining the initial print pattern, and eventually formed a contiguous, luminal 
circle ~ 4mm in diameter (Fig. 12d). These findings indicate mammary epithelial migration 
patterns are not random, rather, the MCF-12A cells actively seek neighboring organoid structures 
to participate in the formation of large structures. Furthermore, when these structures were 
deformed using forceps, they quickly returned to their original shape. Overall, these data clearly 
highlight the tunable nature of our system, where initial cell number and spacing can consistently 
influence the formation of individual MEC organoids. This data also highlights the importance of 
defining and optimizing printing parameters for successful fabrication of large contiguous luminal 












Fig. 12.  Directed printing of non-linear organoids. (a) MCF-12A cells (40 cells per 
deposit) printed in a radial pattern with print spacings of (a) 500µm, 400µm, or 300µm. 
Images of cell clusters illustrate the ability to direct large scale mammary structures 
within 7 days using additional geometric configurations. (b) Fluorescent image of 
bioprinted, RFP MCF-12A cell clusters 14 days post-print demonstrating fusion of 
individual organoids into a contiguous circular organoid. (c) Brightfield image of large 
circular organoid 14 days post-print. (d) Example of a large circular organoid inside 24 
well culture plate 24 days post-print measuring ~4mm in diameter. Scale bar 500µm. 
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Fig. 13.  Alternating RFP/GFP MCF-12A cell deposits to form contiguous organoids. (a) Day 7, and (b) day 9 organoids resulting 
from alternating RFP+ and GFP+ MCF12A cells using a 200µm spacing. Scale bar 200µm. (c)  Immunofluorescence staining of 
Cx32 (red) and GFP (green) in cross-section of an organoid formed as described in a and b. The presence of GFP+ cells along the 
same lumen as RFP cells along with expression of Cx32 along RFP/GFP cell boundaries indicates the cells from adjacent print 
sites intermingled and formed cellular junctions. Scale bar 50µm. 
71 
3.4.5 Organoids Cooperate to Form Gap Junctions with Neighboring Organoids 
Having established the cell number and individual organoid spacing necessary to form 
contiguous organoids, we next sought to determine if our custom 3D bioprinting device could 
introduce multiple cell types within the same linear array. Specifically, we wished to determine if 
we could generate contiguous, luminal structures composed of alternating cell types. To this end, 
we printed equally-spaced 200µm linear arrays of alternating red fluorescent protein (RFP) labeled 
and GFP labeled MCF-12A cells in collagen gels. The RFP and GFP printed cells formed 
contiguous organoids with a central structure and branched extensions with mixed GFP and RFP 
cells by day 7 (Fig. 13a). Separating the fluorescent channels of these structures revealed the 
presence of RFP and GFP labeled cells intermingling with one another within regions of the larger 
structure and branched processes at Day 9 (Fig. 13b). Indication of coordinated cellular behavior 
was further supported by positive staining of gap junction protein connexin-32 (Cx32) between 
RFP and GFP MCF-12A cells along the same lumen (Fig. 13c). This suggests MCF-12A organoid 
formation does not result from one single founder cell, rather, local MCF-12A cell populations 
actively participate in the formation of organoid structures. These results also provide evidence of 
our ability to place more than one cell type (RFP and GFP labeled MCF-12A cells) within close 
proximity. 
3.4.6 Bio-Printing in Additional Sources of Collagen ECM 
While rodent derived collagen models recapitulate many features of human mammary 
gland biology, interspecies variations in ECM composition, organization, density, and function 
exist112. Furthermore, the use of substrata derived from EHS tumors, commercial preparations, or 
other synthetic scaffolds can suffer from batch to batch variability. Given the ability to standardize 
the quantity and spatial distribution of MECs in 3D scaffolds, we set to investigate the ability to 
direct MEC organoid formation in additional sources of ECM using human-derived collagen gels.
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Fig. 14.  Alternating RFP/GFP MCF-12A cell deposits in human collagen. (a) 2 days post-printing.  Scale bar 250µm. (b) Images of breast 
epithelial organoids (250µm initial spacing) 7 days post-printing indicating mix of GFP+ and RFP+ cells in the same structure: GFP (b1), 
RFP (b2), brightfield (b3), and merged (b4). Scale bar 500µm. (c) RFP/GFP structure at 7 days using 500µm initial spacing. Scale bar 
500µm. (d) Higher magnification image of RFP/GFP fusion site. Scale bar 50µm. (e) Higher magnification image demonstrating 
RFP+/GFP+ cells in same ‘lobular’ structure. Scale bar 100µm. (f) Alternating RFP/GFP cell deposits at 500µm in attached, rat tail 
collagen gels failed to result in organoid fusion within 14 days. Scale bar 500µm. 
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To this end, we again printed RFP and GFP labeled MCF-12A cells in 200-500µm linear arrays in 
human-derived collagen gels (Fig. 14a).  After 7 days in culture, RFP and GFP cells within this 
spacing window were observed to contribute to the formation of large, branched structures (Fig. 
14b1-b4). Again, upon closer examination in situ, RFP and GFP cells printed at a 500µm spacing 
were observed intermingling to form a contiguous organoid structure (Fig. 14c,d,e). Data from 9 
wells, each containing 60 target locations, indicated a total of 528/540 neighboring organoid fusion 
events within 7 days post-printing. Further, as a direct comparison, alternating RFP/GFP MCF-
12A cells printed 500µm apart in attached rat tail collagen remained isolated and failed to form 
branched processes (Fig. 14f). These results highlight the ability of 3D bioprinting systems to 
standardize 3D cell culture assays. Moreover, this standardization process can be used to increase 
the validity of investigations aiming to determine the effect of various 3D gel-components on cell 
behavior. 
Histological staining of MCF-12A cells printed in human collagen confirmed the presence 
of GFP and RFP labeled cells within the same lumen (Fig. 15a1-a4). The presence of luminal and 
basal cell populations was confirmed by positive staining of Ck5 and Ck8 in the bioprinted MCF-
12A organoids (Fig. 15b1-b4). Full adhesive function in cell-cell adhesion processes were 
supported by noting positive expression of cadherins and β-catenin (Fig. 15c1-c4). 
Importantly, these results illustrate our bioprinting technique can investigate additional 
ECM preparations while maintaining consistent cell-deposit numbers and spatial distribution of 
printed MECs. Additionally, this data suggests our bioprinting platform and associated methods 
can re-create the unique morphologies observed in attached vs floating gel conditions from manual 
embedding experiments. Also, these results confirmed the phenomena of MCF-12A organoid 
fusion is conserved across additional sources of 3D ECM. Together, we believe these results 
validated our bioprinting methods, and provided valuable insights into the process of MEC 
organoid formation. Furthermore, given our ability to controllably-deposit multiple cell types in 
3D, we believe our bioprinting method possess a greater ability to reproduce a ‘tissue-like’ 
organization than those found in 3D matrix embedding. 
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Fig. 15.  Immunofluorescent staining of MCF-12A cell organoids in human collagen. DAPI 
(a1, blue) indicating total cell nuclei, GFP+ cells (a2, green), RFP+ cells (a3, red). Merged 
image (a4) demonstrates presence of both cell types in the same organoid structure. The 
presence of Ck-5 (b2, green) and Ck-8 (b3, red) indicate the distribution of ‘luminal’ and 
‘basal’ cell populations. Expression of Cadherins and β-Catenin indicate functional cell-
cell adhesion throughout the organoid structure. Scale bar 100µm. 
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3.5 Discussion 
The quest for understanding development and disease in higher organisms has been 
hindered by a lack of investigative tools to accurately and repeatedly control the many variables 
that impact 3D in vitro model systems. A profound example of this is evidenced from the disparate 
results among laboratory-to-laboratory, despite the use of biochemically identical ECM matrices 
and cell types55,59,61,62. In the experiments reported herein, we describe a technique to 
systematically investigate the extent to which cell-cell and cell-ECM interactions act as regulators 
of normal epithelial cell differentiation into well-organized structures.  By standardizing the 
number and position of cells inside pre-formed gels, we have developed a method to help 
standardize the analysis of 3D cultures. 
It has been noted that organoids resulting from single, primary epithelial cells vary in 
morphology and formation efficiency compared to organoids derived from primary epithelial cell 
clusters113. Indeed, we expect the increase in efficiency of our system was due in large part to the 
ability to define the initial proximity of printed cells. This observation is a likely cause of the high 
variability in organoid formation rates seen using manual cell-matrix techniques, where individual 
cell migration within the gel occurs in a random, disorganized manner.  In contrast, printed cell 
aggregates were prone to quickly begin internal organization into cell clusters, which then function 
as a group to seek out neighboring organoids (Sup. Movie 3.1,3.2).  Our quantitative data bolstered 
this idea as the formation frequency of organoids increased significantly when we crossed a critical 
cell number threshold. Furthermore, our data suggest reliable control over both initial cell number 
and organoid spacing permits experimenter directed fabrication of large scale, branched, tubular 
structures of epithelial origin. These data frame the idea that the quantity of inter-cellular 
communications, propagated when cells are initially introduced into a foreign 3D environment, 
can impact the initiation of specific sets of response cascades in developing MEC cell aggregates. 
It has been shown that following stable adhesion to ECM components, the mechanical 
interaction between individual cells and ECM results in the transmission of strain patterns which 
can extend through hundreds of microns of gel56-58. This applied mechanical strain leads collagen 
fibers to orient along the direction of the strain59, which results in increased contact guidance. 
Furthermore, early studies found a preference for MEC organoids to develop along tension lines 
between adjacent organoids within collagen gels60. In a similar manner to which MECs actively 
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seek neighboring organoids in 3D gels, we find morphological patterns appear to be associated 
with the relative position of an individual organoid within the printed array. This may explain our 
observations that organoids seemed to “sense” neighboring organoids; extending processes 
preferentially toward neighboring organoids that ultimately lead to organoid fusion and the 
formation of larger, contiguous structures. Therefore, the ability of this bioprinting method to 
direct organoid growth by manipulating the distances among initial cell-deposits may be directly 
related to this phenomenon. 
Throughout the past decade, testing and controlling microenvironmental aspects of 3D 
culture systems has enabled researchers to bridge the gap between traditional 2D cell culture 
systems and animal models for studying development and tumorigenesis. We used our bioprinting 
device to derive a set of guidelines to enable reliable formation of large-scale, human mammary 
epithelial organoids in 3D collagen I gels. These results demonstrate epithelial organoid 
morphology can be directed by initial cell-deposit number, spacing, and overall print geometry. 
However, the development of actual tissues cannot be reduced to cellular events alone. ECM 
synthesis and assembly in the mammary gland is a dynamic and reciprocal relationship between 
multiple epithelial cell types, myoepithelial cells, adipocytes, endothelial cells, immune cells, and 
fibroblasts. Where the ECM serves to support and instruct cell behavior, cells also continuously 
modify and synthesize ECM112. Therefore, each breast tumor should be seen as a unique, and 
complex organ, which continuously evolves as a result of not only specific mutations and genomic 
instability in individual cancer cells, but also dynamic changes in tumor cell interactions. 
The methods described here demonstrate the capability to accurately deposit multiple cell 
types as neighboring aggregates, which can communicate and synchronize their structure-forming 
activities. Our approach allows direct control over the generation of in vitro constructs large 
enough for in vivo implantation. More importantly, using this system to investigate co-cultures of 
two or more cell types in a defined microenvironment would greatly increase the ability to develop 
reliable 3D surrogate models for breast development and carcinogenesis.  This is of interest to our 
group, as we have great interest in understanding how the microenvironment controls 
differentiation of stem and cancer cells114-122.  We plan to adapt these protocols for the development 
of chimeric structures containing cancer and normal epithelial cells as in vitro models that mimic 
our previous in vivo findings. Since in vivo model systems are costly and complex, our 3D 
bioprinting technology stands as the obvious choice for developing physiological, 3D model 
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systems using human cells to create the appropriate contextual cues. Furthermore, we expect the 
processes outlined here to be easily adaptable to other epithelial cell types, including endothelial 
cells, to study vascularization and development in other tissue types. 
3.6 Conclusion 
These data demonstrate that our CNC driven, 3D bioprinter is capable of repeatable and 
reliable printing of MEC structures. Furthermore, through coordinated cluster placement, our 
system can generate consistent, large contiguous luminal structures containing more than one cell 
type. Furthermore, due to the digital transfer of instructional GCODE files, the results of these 3D 
bioprinting experiments could easily be replicated in other laboratories with a similar 3D 
bioprinting platform. This paradigm could engender a digitization of biological experimentation 
that would lead to consistent laboratory-to-laboratory research, improving the ability to progress 
cancer research-to-cures. Thus, these results indicate we successfully achieved our second 
objective. 
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To me life consists simply in this, in the fluctuation between 
two poles, in the hither and thither between the two 




3D BIOPRINTING CHIMERIC MEC ORGANOIDS 
4.1 OVERVIEW 
A mounting body of evidence suggests the context and status of cellular interactions within 
the microenvironment are a key determinant of whether cells within a tissue retain their normal 
architecture or undergo tumor progression26,123,124. This conclusion was largely made evident 
through co-culturing stroma from one type of tissue with epithelial cells from a different tissue, 
frequently known as chimeric models 26,125-127. In vivo, chimeric-recombination models first 
identified the unique ability of tissue stroma to influence the developing epithelium128. For 
example, when mammary epithelium was recombined with salivary gland mesenchyme, structures 
that resembled salivary gland epithelium were generated129. Additionally, salivary epithelium 
outgrowths in contact with mammary mesenchyme resembled a mammary gland ductal tree, 
became competent for lactation, and responded to hormonal stimuli130. Astonishingly, it has been 
demonstrated that the regenerating mouse mammary gland can reprogram testicular cells, neural 
progenitors, bone marrow and breast cancer cells to adopt a normal mammary progenitor cell 
fate114,116,128,131,132. These studies revealed the highly malleable status of the epithelial component 
and the importance of the in vivo components of the gland for tissue function and cell fate. 
While the accrual of these results highlights the need to investigate the identities and 
molecular mechanisms involved in this process, it is much more challenging to directly and non-
invasively image tumor-cell interactions as they begin to occur in vivo. Furthermore, identifying 
aspects of these mechanisms has been problematic because it is difficult to isolate the effects of an 
individual stimulus on cell behavior in vivo. Additionally, it should be noted that while gland 
reconstitution studies have been able to identify the regenerative capacity of the mammary stem 
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cell, gland reconstruction likely involves injection site wounding, which may induce different fate 
decisions than those occurring during normal gland development3. Also, these investigations lack 
sufficient methods for maintaining cells in close proximity once implanted in vivo22,24,133,134. 
In an effort to study these systems in a more definable space, in vitro 2D cell culture has 
traditionally been employed. Yet, 2D cell cultures are largely non-biomimetic, and as a result, cell-
signaling networks are altered in 2D environments. Many investigations have illustrated 3D 
architectures are necessary to elicit the functional organization and cellular relationships of the in 
vivo environment51. For these reasons, 3D in vitro and ex vivo cell culture systems represent an 
indispensable tool to investigate the processes related to tissue and tumor formation. However, 
previous models of 3D tumor biology, such as tumor organoids, are incapable of fully addressing 
the developmental cues associated with the human cancer ecosystem. Therefore, these systems are 
becoming increasingly complex by the incorporation of additional cell types. Co-cultures of 
stromal and tumor cells, and even tri-cultures of MECs, human fibroblasts and adipocytes have 
been developed to elicit a physiologically relevant, 3D culture surrogate of complex human breast 
tissue135-137. 
3D in vitro co-cultures of stromal and tumor cells, and even tri-cultures of MECs, human 
fibroblasts and adipocytes have been developed to elicit a physiologically relevant, 3D culture 
surrogate of complex human breast tissue61,135-138. Importantly, these in vitro investigations have 
been able to show that restoring the correct level of microenvironmental signaling can ‘revert’ the 
malignant phenotype of breast tumor cells, despite the complete retention of the malignant 
genome63,139-142. For example, by screening seven BRAFV600E mutant melanoma cell lines with 18 
stromal cell lines, researchers uncovered a novel mechanism of vemurafenib resistance mediated 
by secretion of hepatocyte growth factor by six of the co-cultured stromal cell lines143. Thus, there 
exists a growing need to develop advanced 3D cell culture models comprised of multiple cell types 
to decrypt aspects of intra- and intercellular signaling, and the context-driven contributions of 






Despite the incorporation of additional cell types in 3D culture models, many components 
of the in vivo microenvironment remain a mystery. This shortcoming may be related to the limited 
availability of suitable technological and analytical methods to investigate these144. For example, 
the standard 3D culture procedures utilized by many of these investigations rely on randomly 
mixing ratios of cells with ECM substrates prior to gelling, or by seeding cell mixtures on top of 
a pre-formed ECM gel. Therefore, the size and morphology of resulting organoids vary greatly, 
which leads to difficulty in interpreting and reproducing experimental results145. 
One potentially controllable, yet major source of the variability of current 3D culture 
systems stems from the manual cell-matrix embedding methods that yield a random distribution 
of cells in the gel. Advances in 3D cell culture technologies, especially accessible 3D bioprinting 
devices, have recently demonstrated the ability to reliably, and repeatedly generate arrays of small-
volume, cell-deposits containing user-specified cell numbers ranging from 1 to hundreds, with 
spatial resolutions below 50µm108. Furthermore, these devices have demonstrated the ability to 
fabricate, large-scale epithelial organoid-structures. Herein, we describe the first example of 3D 
bioprinting technology to facilitate chimeric structure formation between non-tumorigenic human 
MECs (MCF12A) and either of two human tumorigenic cell lines: luminal epithelial mammary 
cell line MCF-7 and metastatic adenocarcinoma mammary breast cancer cell line MDA-MB-468 
in a 3D collagen gel system. 
We demonstrate how this technology not only promises to standardize 3D culture assays, 
but also provides an efficient method to introduce additional cell types into developing and 
previously-established MEC organoid structures. Principal findings indicated a significantly 
enhanced ability to generate chimeric organoids as compared to matrix embedding methods. Both 
MCF-7 and MDA-MB-468 cells survived and incorporated into MCF-12A organoids to form 
chimeric structures. Additionally, the morphological behaviors of both tumorigenic cell lines 
inside chimeric structures was unlike those in control (tumor-only) structures. Histological staining 
indicated tumor cells expressed cadherin and connexin proteins on borders with MCF-12A cells 
in chimeric structures, suggesting the two cell types formed adherens junctions and gap junctions 
under these conditions. Interestingly, by immunofluorescence, both tumorigenic cell lines in 
chimeric structures exhibited β-catenin staining similar to adjacent MCF-12A cells. Furthermore, 
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by using human derived ECM substrates, our 3D bioprinting system offers an innovative platform 
for generating a fully human, in vitro model to dissect cell-cell interactions, the effects of 
microenvironment on cell function, and the effects of different genetic or non-genetic 
modifications on mammary cell transformation. These findings are, to the best of our knowledge, 
the first demonstrations of the capacity of 3D bioprinting devices to mediate and direct the 
formation of chimeric MEC organoid-structures in fully human, 3D culture environment. 
4.3 Materials and Methods 
4.3.1 Cell Culture 
Immortalized non-tumorigenic human breast epithelial cell line, MCF-12A, and MCF-7 
and MDA-MB-468 breast carcinoma cell lines were purchased from ATCC. All cells were 
maintained on 2D tissue culture plastic. MCF-12A cells were initially cultured in 2D on tissue 
culture plastic in a 75 cm2 flask supplemented with a 1:1 mixture of Dulbecco’s modified Eagle’s 
medium and Ham’s F12 medium (DMEM/F12), 5% Horse Serum, 20 ng ml-1 hEGF, 0.01 mg ml-
1 bovine insulin, 500 ng ml-1 hydrocortisone and 1% ABAM (all purchased from ThermoFisher). 
MCF-7 and MDA-MB-468 cells were maintained in Dulbecco’s Modified Eagle’s Medium 
supplemented with 10% fetal bovine serum (FBS, Life Technologies) and 1% ABAM. All cells 
were cultured at 37.0°C and 5.0% CO2. After confluence, the cells were dissociated using TrypleE 
(ThermoFisher) and collected by centrifugation. Chimeric organoids were cultured using 1:1 
mixture of Dulbecco’s modified Eagle’s medium and Ham’s F12 medium (DMEM/F12), 5% 
Horse Serum, 20 ng ml-1 hEGF, 0.01 mg ml-1 bovine insulin, 500 ng ml-1 hydrocortisone and 1% 
ABAM (ThermoFisher). 
MCF-12A cells are considered a model for normal human MECs. The MCF-7 cell line 
represents a rapidly growing, luminal carcinoma cell line that is E-cadherin positive, vimentin 
negative, estrogen receptor-positive, and non-invasive146. MDA-MB-468 cells are EGF receptor 




4.3.2 Preparation of 3D Collagen ECMs for Bioprinting and Manual Cell-Matrix Embedding 
For manual cell-matrix embedding studies, single cell suspensions of MCF-12A cells were 
mixed with neutralizing solution and acidified rat tail collagen I (Corning) as specified by the 
manufacturer, to a final concentration of 1.3 mg/ml. For chimeric studies, MCF-12A cells were 
mixed with one of the two tumorigenic cell lines at a 1:5 ratio. Immediately after mixing, 500µl of 
neutralized collagen I gel material containing approximately 5000 cells (6000 cells for chimeric 
studies) was dispensed into a 24 well plate and allowed to solidify and adhere to the surfaces of 
the well for 1 hour in a laboratory incubator at 37.0°C and 5.0% CO2. After gelation 
(solidification), 500µl of cell appropriate cell media was added to the wells. MCF-12A media was 
used for all chimeric studies. Subsequent media changes were performed every 3 days. 
VitroCol, human collagen I solution (Advanced BioMatrix), was prepared according to 
manufacturer’s recommendation to a final concentration of 1.0 mg/ml. For all printing 
experiments, a minimum of 500µl of collagen gel was dispensed into individual wells of a 24 well 
plate and allowed to solidify for 1 hour in a laboratory incubator at 37.0°C and 5.0% CO2.  
4.3.3 Bioprinting System 
A previously developed bioprinting system was used to robotically dispense cells into 
specified 3D locations of a polymerized collagen gel108. Briefly, neutralized collagen I gel material 
was dispensed into a 24 well plate and allowed to solidify and adhere to the surfaces of the well in 
a laboratory incubator at 37.0°C and 5.0% CO2. Before printing operations, 2D cultures of MCF-
12A, MCF-7 and MDA-MB-468 cells were dissociated into single cells using TrypleE 
(ThermoFisher), centrifuged at 300×g, and re-suspended in media to obtain a final ‘ink’ 
concentration of 60×104 cells ml-1. For chimeric experiments, printing operations were optimized 
to extrude specified numbers of cells inside the collagen I gel via a CNC insertion routine which 
deposited cell containing media at a specified ‘target’ location inside the polymerized collagen I 
gel. Users specified intended wells of commercially available tissue culture plates, printing 
locations, distances among printing locations, and the number of cells per target location. The 
experiment information was automatically converted into G-code, loaded into Repetier Host, and 
sent to the three-axis microcontroller of the bioprinter. The bioprinting system was located inside 
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a benchtop biosafety cabinet during all printing operations. The heated print bed was set to 37° for 
all printing operations. 
4.3.4 Characterization of Organoid Growth and Morphology 
Immediately after printing, the initial quantity of printed cells was verified using manual 
counting and image analysis using ImageJ and Matlab. Post-printing, cells were monitored up to 
21 days using a combination of bright field imaging/fluorescent imaging using a Zeiss axio-
observer Z1 fluorescent microscope, or time-lapse imaging using a Lumascope 620 microscope. 
The size of organoids was determined by analyzing bright-field images taken daily for each 
experimental condition using ImageJ. Within this investigation, organoids were operationally 
defined as a cluster of cells with no clear cell-cell boundaries, or the inability to discern individual 
cells from neighboring cells. The organoid formation rate for manual matrix embedding was 
calculated using the following equation: (number of organoids per well / number of cells seeded 
per well) ×100%. The organoid formation rate for bioprinted organoids was calculated using the 
following equation: (number of organoids per well / number of printed target sites) ×100%. 
4.3.5 Immunofluorescence Staining 
Gels were fixed in 10% neutral buffered formalin, paraffin embedded and sectioned.  
Sections were prepared for staining by deparaffinizing in a xylene substitute, rehydration, and 
heat-mediated antigen retrieval using pH 9 tris-edta with 0.05% tween 20. Sections were blocked 
in 10% goat serum and incubated with primary antibodies in a humidified chamber at 4°C 
overnight. Secondary antibodies were added for 1 hour at room temperature. Sections were 
counterstained with DAPI. 
Antibodies were used at the following concentrations: mouse monoclonal antibody to 
BetaCatenin [12F7] (1:50; ab22656, Abcam), anti-green fluorescent protein rabbit IgG Alexafluor 
488 conjugated ( 1:75; Invitrogen A21311); rabbit monoclonal antibody to cytokeratin 5 
[EP1601Y] (1:75; ab52635, Abcam), mouse monoclonal antibody to cytokeratin 8 [C-51] (1:35; 
ab2531, Abcam), rabbit anti-pan-cadherin (1:75; 71-7100, ThermoFisher), rabbit polyclonal 
antibody to GJB6 [Cx30] (1:25;  HPA014846, Sigma-Aldrich), and rabbit polyclonal antibody to 
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GJB1 [Cx32] (1:25; HPA010663, Sigma-Aldrich). Appropriate Alexafluor 488 and 568 
conjugated goat antibodies (1:1000; ThermoFisher) were used for secondary antibody labeling. 
All sections were counterstained with DAPI and imaged using a Zeiss axio-observer Z1 fluorescent 
microscope. 
4.3.6 Statistical Analysis 
Values represent mean ±standard deviation of samples measured in triplicate. Data 
represent more than three independent experiments. Results were assessed for statistical 
significance using Student’s t test. Differences were considered statistically significant at *p < 
0.05. 
4.4 Results 
4.4.1 Reliable Generation of Mammary Epithelial Tumor Organoids 
To establish baseline behaviors of MCF-7 and MDA-MB-468 cells in 3D collagen cultures, 
we first employed our bioprinting device to generate arrays of tumor cells in polymerized collagen 
gels. Our bioprinting method utilized CNC processes to controllably-deposit cells in 3D locations 
of polymerized collagen I gels (Fig. 16a1,b1). Results indicated both tumor cell lines proliferated 
and formed structures post-printing (Fig. 16a1-a4,b1-b3). Our bioprinting assay identified a 
discrepancy between the growth morphologies of the two tumor cell lines throughout the 21-day 
culture period. MCF-7 tumor cells formed compact, sphere-like structures with little evidence of 
coordinated growth among neighboring organoids, indicative of their previously known, non-
invasive character (Fig. 16c). On the other hand, MDA-MB-468 cell growth illustrated the 
opposite effect, where invasive tumor cells equally dispersed into all radial directions of the 
Collagen I matrix, which resulted in a large, disordered structure lacking defined boundaries (Fig. 
16d). H&E sectioning of bioprinted arrays confirmed cell free regions between MCF-7 print 
locations, which supports the notion that MCF-7 cells do not readily migrate through collagen I 
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(Fig. 16c,e). The opposite effect was confirmed in sections of arrays containing MDA-MB-468 
cells, where cells and small cell clusters appear dispersed throughout the gel (Fig. 16d,f). 
Fig. 16.  3D Bioprinting consistent breast tumor organoids. (a1-4) MCF-7 cell deposits (40 
cells/deposit) spaced 300µm apart at 1, 7, 14, and 21 days post-printing. Scale bar 1 mm. 
(b1-b3) MDA-MB-468 cell deposits (40 cells/deposit) spaced 300µm apart at 1, 14, and 21 
days post-printing. Scale bar 1 mm. Reliable formation of (c) MCF-7 and (d) MDA-MB-
468 tumor organoids at 21 days. Scale bar 500μm. H&E stain of (e) MCF-7 and (f) MDA-
MB-468 tumor organoids at 21 days. Scale bar 150µm. 
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Fig. 17.  Histological analysis of bioprinted MCF-7 breast tumor organoids. MCF-7 cell 
organoids exhibited weak cadherin, and β-catenin staining. Ck-5 was not detected among 
MCF-7 cells, however MCF-7 cells were Ck-8 positive. Expression of Cx-32 was 
observed. Scale bar 50µm. 
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Fig. 18.  Histological analysis of bioprinted MDA-MB-468 breast tumor organoids. Cadherin and β-catenin staining in 
MDA-MB-468 tumor cell organoids. MDA-MB-468 tumor organoids were Ck-5 and Ck-8 positive. Variable expression 
of Cx-30 and Cx-32 was observed. Scale bar 50µm. 
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Fig. 19.  Comparison of 3D bioprinted, epithelial organoid-structures. MCF-12A cells form epithelial organoids with a luminal 
cavity, express Pan-Cadherin, and express β-Catenin. Tumorigenic cell-organoids from MCF-7 cells displayed less intense Pan-
Cadherin signal and were β-Catenin positive. Tumorigenic cell-organoids from MDA-MB-468 cells express cadherin and β-




Fig. 20.  Collagen density affects morphology of MCF-7 organoid structures. 
Immunohistochemical analysis of 3D bioprinted, MCF-7 tumor organoids in 0.5 mg/ml 
collagen gel indicated MCF-7 organoid-structures under these conditions were cadherin 
and β-Catenin positive, and express both Ck-5 and Ck-8. Lower density collagen gels 
increased the ability of 3D bioprinting to direct MCF-7 organoid fusion. Scale bar 50µm.  
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To further illustrate the ability of our bioprinting device to standardize 3D culture assays, 
we printed MCF-7 cells in 0.5 mg/ml collagen gels (Fig. 20). In the 0.5 mg/ml collagen gel, around 
MCF-7 cells expressed myoepithelial marker Ck5 (Fig. 20), whereas no staining was observed in 
1.0 mg/ml gels (Fig. 17), suggesting that luminal and basal specific markers were co-expressed in 
the cells grown in the less dense collagen. However, MCF-7 cells were still Ki67 positive in 0.5 
mg/ml collagen gels, which suggests the cells still retained a highly proliferative phenotype (Fig. 
20). However, reducing the density of the collagen matrix resulted in the opposite growth 
morphology seen in (Fig. 16c). While MCF-7 cell organoids in 1.0 mg/ml collagen were unable to 
reliably undergo coordinated organoid fusion within 7 or 14 days, individual MCF-7 cell-
organoids were able to fuse within 5 days post-printing in the less dense 0.5 mg/ml collagen gel 
(Fig. 20). These data suggest that MCF-7 cell behavior differs among different culture conditions 
and highlights the ability of bioprinting devices to standardize the comparison of experimental 
results through the reliable patterning of cell quantities. 
4.4.2 Proliferation in MCF-12A, MCF-7, and MDA-MB-468 Cells. 
To provide a better understanding of the differences between MCF-12A cells and 
tumorigenic cell lines in collagen gels, we used manual scoring methods to assess for differences 
in levels of proliferation by immunostaining for a proliferating-cell antigen, Ki67. Compared to 
normal MCF-12A cell structures (Fig. 21a), the number of proliferating epithelial cells was 
significantly higher in tumorigenic MCF-7 (*p < 0.01) (Fig. 21b,d) and MDA-MB-468 cell 
structures (**p < 0.005) (Fig. 21c,d). This confirmed the highly proliferative status of both 












Fig. 21.  Quantitative analysis of Ki-67 positive epithelial cells 
grown in 1.0 mg/ml collagen gel. (a) MCF-12A, (b) MCF-7, 
(c) MDA-MB-468 stained for Ki-67 (GFP) and nuclear stain 
DAPI. Scale bar 100µm. (d) Compared to MCF-12A cell-
organoids, tumor-organoids contain significantly higher 
numbers of proliferating cells in collagen gels. *p  < 0.01; **p 
< 0.005. 
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Fig. 22.  Bioprinted multicellular assays are more efficient than manual method. (a) Results from manual method at 1, 3, 7, and 14 
days in culture. Scale bar 200µm. Unlike the random cell distribution in manual methods, 3D bioprinted tumorigenic cells are 
immediately exposed to normal MECs. (b) Day 1 result of bioprinted mixture of GFP labeled, tumorigenic cells (MDA-MB-468) 
and RFP labeled MCF-12A cells. Scale bar 100µm. (c) Day 3 results of bioprinted tumorigenic (GFP) and normal (RFP) MEC cells. 




Fig. 23.  Within 7 days, 3D bioprinting enabled the reliable formation of large chimeric mammary 
epithelial organoid-structure containing (a) tumorigenic cells (MDA-MB-468) and (b) ‘normal’ 
MCF-12A cells. (c) Organoid -structure illuminated with brightfield. (d) Merged image 
demonstrating the presence of both cell types in organoid-structure. Scale bar 500µm. 
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Fig. 24.  Within 21 days, initial mixtures of ‘normal’ MCF-12A cells and tumorigenic cells MDA-
MB-468 undergo coordinated organoid fusion events to generate a large chimeric epithelial 
organoid-structure. Example of (a) tumorigenic cells (MDA-MB-468) located among (b) 
‘normal’ MCF-12A cells. (c) Organoid -structure illuminated with brightfield. (d) Merged image 
demonstrating the presence of both cell types in organoid-structure. Scale bar 500µm. 
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4.4.3 Generation of Chimeric Structures in a 3D Gel 
Given the need to develop high-throughput, in-vitro models to investigate the role of the 
microenvironment on epithelial biology in 3D, we began by determining the effectiveness of 
manual cell-matrix embedding to generate chimeric cell-organoids (Fig. 22a). Consistent with 
previous in vivo demonstrations, our in vitro chimera studies used a 5:1 ratio of normal to 
tumorigenic cells128. Thus, 1000 cells from a single tumorigenic cell line were mixed with 5000 
MCF-12A cells, added to unpolymerized collagen I gels and pipetted into wells of a 24 well plate. 
Under these conditions, MECs and tumorigenic cell lines were able to generate chimeric organoid 
structures during the 21-day culture period (Fig. 22a). However, there were severely limiting 
quantities of chimeric organoids, further complicated by the excessive number and random 
distribution of MCF-12A organoid-structures. 
Having visually identified chimeric tumorigenic cells in MCF-12A organoids, we next 
sought to guide the formation of chimeric organoids using our custom bioprinting system. We 
previously described our ability to standardize the frequency of organoid formation through 
control of the initial cell quantities within bioprinted cell-deposits; cell-deposits containing at least 
40 cells formed organoids within 7 days post-printing (Fig. 9). Using this 40-cell standard, we 
dispensed a 5:1, MCF12A to cancer cell mixture at volumes equivalent to 40 cells in equally-
spaced linear arrays inside collagen I gels. Unlike the random cell distribution of manual 
embedding, our bioprinting method maintained GFP-labeled tumorigenic cells within the 
immediate vicinity of RFP-labeled MCF12A cells post-printing (Fig. 22b). After 3 days, both 
GFP-labeled tumorigenic cell lines showed signs of initial cell-cell clustering associated with 
developing MCF-12A organoid structures (Fig. 22c). Within 5 days, we observed behavioral 
discrepancies between the two tumor types in the RFP-MCF-12A organoids. GFP-labeled MDA-
MB-468 tumorigenic cells were often found equally dispersed, in single cell quantities throughout 
RFP-MCF12A organoid-structures (Fig. 22d).  
After 1 week in collagen gels, bioprinted cell clusters containing normal and tumorigenic 
cell types fused with neighboring organoids into large-epithelial organoid-structures with branched 
extensions directed into unoccupied areas of the gel (Fig. 23a-d). Interestingly, time-lapse imaging 
indicated both MCF-7 and MDA-MB-468 tumorigenic cell lines interact with MCF-12A cells, and 
actively migrate inside MCF-12A organoids (Sup. Movie 4.1, 4.2). After 3 weeks in culture, the 
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cell clusters formed into large, contiguous epithelial- structures, containing chimeric constituents 
from both cancer cell lines (Fig. 24a-d). Importantly, as these structures began to generate 
branched extensions, tumor cells remained equally dispersed within the networked structures (Fig. 
24a). Together, these results indicate our bioprinting process effectively generates chimeric 
structures, which holds the potential to mimic the incorporation of cancer cells within normal 
mammary structures previously described in vivo. These findings indicate our bioprinted chimeric 
structures represent the state of the art system for studying not only cancer cell redirection, but 
also studies of MEC tissue morphology, and the developmental processes associated with 
generating the hollow structures similar to ducts seen in vivo.  
4.4.4 Quantification of Chimeric Organoid Formation 
Surveys of manually-embedded gels indicated the initial 5000 MCF-12A cell-quantity 
resulted in a total of 929± 265 and 1060 ± 209 MCF-12A organoids at 7 and 14 days. Given the 
1:5 ratio of tumorigenic cells in the initial cell mixtures of chimeric experiments, we expected to 
observe tumorigenic cells among 200 of the 1000 MCF-12A organoids in the embedded gels. Yet, 
among these organoids, only 2.3 ± 0.5 and 5.5 ± 1.3 chimeric organoids were observed at 7 and 
14 days, respectively (Table 2). Thus, generating chimeric organoids using manual embedding 















Table 2.  Evaluation of chimeric organoid formation. 
Compared to manual cell embedding, 3D bioprinted 
cell mixtures form significantly more chimeric 
organoid-structures. **p < 0.001; *p < 0.01. 
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Among experiments with 36 bioprinted cell-deposits, 34.7 ± 1.6 and 32.2 ± 3.8 chimeric 
cell-organoids formed at 7 and 14 days, respectively (Table 2). Thus, bioprinted cell mixtures 
corresponded to a 96.4 % and 89.5 % chimeric organoid formation frequency at 7 and 14 days. 
When compared to manual methods, the number of bioprinted chimeric organoids increased 
significantly after both 1 week (**p < 0.001) and 2 weeks (*p < 0.01) (Table 2). Overall, this data 
highlights the increased efficiency of our 3D bioprinter to generate chimeric organoid-structures 
compared to manual matrix embedding procedures. 
4.4.5 Distribution of Junctional Proteins in Chimeric Organoids 
We next aimed to characterize the chimeric structures to determine their behavior when 
introduced into mammary epithelial organoids. To do this we immunoassayed slides using 
antibodies for tumorigenic cells (anti-GFP) confirming the presence of tumorigenic cell types 
inside MCF-12A organoids (Fig. 25). Cadherin staining indicated both MCF-7 and MDA-MB-468 
cells express cadherins in chimeric organoids (Fig. 26).  
Positive staining of gap junction proteins Cx30 and Cx32 between tumorigenic and MCF-
12A cells in chimeric organoids suggest tumorigenic cells may form gap-junctions with MCF-12A 
cells in chimeric organoids (Fig. 23). These results indicate maintaining the two cell types in close 
proximity is effective for generating chimeric organoids, and also provide evidence of cell-cell 





Fig. 25.  Distribution of normal and tumorigenic cell types in chimeric organoids. Fluorescent microscopy confirmed the presence 
of GFP+, tumorigenic cell lines (MCF-7 or MDA-MB-468) inside MCF-12A organoid-structures. β-Catenin staining of MCF-12A 
and either tumorigenic cell line in chimeric organoids indicated all cell types were β-Catenin positive. Scale bar 100µm. 
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Fig. 26.  Immunohistochemical comparison of cadherin expression in chimeric epithelial organoids. Examples of chimeric, epithelial 
organoid structures containing MCF-12A cells (shown in green) and either tumorigenic cell line (MCF-7 and MDA-MB-468) identified 
with arrows. Histological observations using pan-cadherin antibodies indicated MCF-7 cells within chimeric structures display less 
intense staining than neighboring MCF-12A cells. Pan-Cadherin staining in MDA-MB-468 cells exhibited more variable intensities. 




Fig. 27.  Immunohistochemical comparison of connexin expression in chimeric epithelial 
organoids containing MCF-7 and MCF-12A cells. MCF-7 cells appear to display a decreased level 
of Cx-30 compared to neighboring MCF-12A cells. Cx-32 staining appears more variable in MCF-
7 cells, however both MCF-7 and MCF-12A cells appear to express Cx-32. Scale bar 25µm. 
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Fig. 28.  Immunohistochemical comparison of connexin 30 (Cx30) expression in chimeric epithelial 




Fig. 29.  Immunohistochemical comparison of connexin 32 (Cx32) expression in chimeric 
epithelial organoids containing MDA-MB-468 and MCF-12A cells. White arrows indicate MDA-
MB-468 tumor cells. (b) Both cell types express Cx32. (c) MCF-12A cells shown in green. (d) 
Merged image. Scale bar 50µm.  
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Fig. 30.  Manipulating cell-cell interactions through bioprinting. (a) Day 3 results of GFP-MDA-MB-468 cell deposits spaced in-
between MCF-12A cell deposits. Scale bar 200µm. (b) By day 7, MDA-MB-468 cell-extensions emerged from the end of the printed 
array. Scale bar 200µm. 
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Fig. 31.  Alternative methods for generating chimeric organoids. (a) GFP+ MDA-MB-468 cells 
and RFP+ MCF-12A cells printed independently as concentric rings. (b) By day 5, individual 
cell deposits fuse together to form a larger structure composed of both cell types. Scale bar 
500µm.Tumorigenic cell types (c) can be introduced into previously developed MCF-12A cell-
organoids (d). Evidence suggests some GFP+ MDA-MB-468 cells were successfully 
incorporated inside MCF-12A organoid structures from previous 21-day cultures. Scale bar 
100µm. 
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4.4.6 Manipulating Microenvironmental Cues Through Bioprinting 
In addition to increased efficiency, our bioprinting device also provides the ability to 
generate unique combinations, geometric configurations, and temporal additions of multiple cell 
types. Previously, we described organoid fusion events, where neighboring MECs initiate the 
formation of directional extensions to generate organized, large epithelial structures. Presumably, 
the areas where these restructuring processes occur contain ‘normal’ developmental cues. To 
determine if human cancer cell organoids could be influenced by these interactions, we utilized 
our bioprinting apparatus to place tumor-only cell-deposits between normal-MEC cell-deposits in 
equally spaced, linear arrays. Within 3 days, GFP-labeled MDA-MB-468 cells located in-between 
MCF-12A organoids appear to conform to the directional orientation of the merging MCF-12A 
structures in the bioprinted array (Fig. 30a, Sup. Movie 4.3). MDA-MB-468 cells located in-
between normal organoids were incorporated into large, chimeric organoid structures (Fig. 30b). 
In addition to placing tumor cells between normal cell-deposits, we also wanted to determine the 
possibility of generating chimeric organoids by printing tumor and normal cells as separate, 
concentric rings (Fig. 31a). Within 5 days, we observed the formation of chimeric organoids, and 
no remaining evidence of the separate rings was present (Fig. 31b). These results suggest organoid 
formation is not limited to initial cell mixtures alone. Specifically, neighboring MCF-12A cells 
can influence the directional growth of tumor-only cell-deposits. 
In addition to investigating tumorigenic responses to developing MEC organoids, we 
evaluated the potential use of our bioprinting device to deposit cells in mature stages of organoid 
development. To this end, we were able to successfully introduce tumorigenic cells into an 
established, 3-week culture containing mature MEC organoid-structures (Fig. 31c,d). These results 
indicate the bioprinting methods described here are capable of placing multiple cell types in more 






This work provides a description of how bioprinting technology can be utilized to 
standardize current and future chimeric models of 3D epithelial cell culture assays. As such, 3D 
bioprinting platforms are ideally suited to facilitate the high-throughput analysis of potential 
mechanisms related to cancer cell redirection. To reliably recreate ‘context’ in vitro requires 
technologies capable of investigating how multiple cell types elicit changes in ECM before, during 
and after organoid development112. Conventional methods for studying tumor cell behaviors have 
relied on injection of tumor cells into cleared mammary fat pads, Boyden assays, or random 3D 
matrix embedding assays. While each of these methods offers its own advantages, they are difficult 
to optimize for visualization and biophysical parameter control, such as spatial and temporal 
control over experimental conditions. This report provides evidence of the superiority of 
bioprinting systems over conventional methods for studying tumor cell behaviors, particularly in 
the context of cancer cell redirection. Furthermore, the ability to introduce tumorigenic cells into 
epithelial organoid-structures from 21-day cultures of MCF-12A cells suggests our bioprinting 
method is not limited to a single, initial cell placement. This advantage gives us the ability to ask 
previously unanswerable, interesting questions such as: what would happen if we introduced 
‘normal’ cell types into established tumor organoids? 
We report the ability to generate chimeric epithelial structures containing focal outgrowths 
that radially expand into unoccupied regions of a collagen I gel. After a few days post-printing, 
these foci of epithelial growth show a centrally located lumen and the earliest development of a 
duct, and what appears to be a ‘TEB-like’ structure. By standardizing the process of 3D mammary 
epithelial organoid formation, we believe this system may provide a potential method to reliably-
investigate the contextual properties of the in vivo situation. 
Understanding the bidirectional communication between tumor cells and their 
microenvironment represents a powerful, advantageous way to investigate the mechanisms that 
influence disease promotion and progression. Furthermore, identifying the contextual 
contributions related to ‘normalizing’ or reversing the tumor-specific ECM associated with cancer 





The study of breast cancer itself has ‘evolved’ in the past decade; research has migrated 
away from 2D culture and xenotransplantation, towards fully-humanized, 3D model systems. But, 
as with most things, our ability to address the experimental complexity required to further scientific 
investigations of this disease have been limited due to a lack of available technology. Through the 
ability to create and control 3D environments with a significantly increased level of precision, our 
bioprinting platform represents a scientific ‘catalyst’ to further advance the capabilities of in vitro 
models of numerous biological systems. While the experiments reported here represent the 
successful achievement of the last objective of this work, this achievement represents just the 
beginning of our main aim to incorporate this powerful technology to design personalized 
‘microenvironments’ that better recapitulate the in vivo situation. Specifically, incorporating 
multiple cell-lines with reporter genes in our organoid arrays may provide a further method to 
systematically identify the factors that are integral to the normal niche, and thus sufficient to direct 
neoplastic mammary cells toward normal cell behavior. As our understanding of biological 
systems continues to develop in breadth and complexity, the ability to use bioprinting to assist in 
any combinatorial approach to model these dynamic interactions may be the only means necessary 
to fully comprehend the roles of the numerous agents involved in most biological systems. 
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We shall not cease from exploration, 
And the end of all our exploring 
Will be to arrive where we started 
And know the place for the first time. 
T. S. Eliot 
 
CHAPTER 5 
SUMMARY AND FUTURE WORK 
5.1 Summary of the Current Study 
In this study, we addressed the need to further technical advances towards the development 
of disease models using 3D, in vitro cell cultures that accurately recapitulate the in vivo situation. 
While 3D bioprinting technology is not new, the technology has yet to be heavily incorporated in 
current experimental techniques due to the uncertainty as to whether the research benefit will 
outweigh the operational cost. Furthermore, most commercially available 3D bioprinters are 
unable to address the unique research demands of individual research labs. Importantly, this work 
identified the need to overcome the limitations imposed by conventional, ‘luer-lock’ syringe 
systems in commercially available bioprinters. Furthermore, the custom system demonstrated the 
ability to handle precise cell quantities, without compromising fragile cell types. Thus, we believe 
we were successful in completing the first objective of this investigation, to design and develop 
3D bioprinting technology capable of completing experimental tasks related to precision cell 
handling. 
Next, we utilized our system to address the experimental inconsistency of manual cell 
matrix embedding techniques commonly used in MEC research. Results showed that placing 
multiple cells in confined locations is a viable method for generating arrays of bioprinted, MEC 
organoids. Results indicated a positive relationship between the number of initial cells and the 
amount of time required for MEC organoid formation. Importantly, our 3D bioprinted MEC 
organoids were of uniform size and morphology, indicating this method is sufficient for 
eliminating the experimental inconsistency associated with manual methods.  
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We then used the bioprinting platform to identify effective distances to generate large, 
epithelial structures that resembled the initial print geometry. This organoid ‘fusion’ process was 
further investigated by patterning alternating GFP and RFP-labeled MECs in a single, bioprinted 
array. After 14 days in culture, results indicated neighboring RFP and GFP-labeled cell-deposits 
underwent coordinated, interacting behaviors to generate a contiguous RFP/GFP epithelial 
structure. Overall, these results highlight the ability of 3D bioprinting to direct individual organoid 
formation, and to control the ‘self-assembly’ of large epithelial structures through coordinated, 
organoid fusion events. These findings indicate we successfully completed our second main 
objective, which was to identify the parameters associated with reliable MEC organoid generation 
and the ability to direct the formation of large epithelial structures using 3D bioprinting.  
Given the importance of the cellular environment in regulating cellular signaling, we 
investigated the ability of our bioprinting platform to further advance in vitro methods for the study 
of cell-cell interactions among tumorigenic cell lines (MCF-7, MDA-MB-468) and normal cell 
line (MCF-12A). As expected, when compared to manual embedding methods, 3D bioprinted co-
cultures of MCF-12A and either tumorigenic cell line (MCF-7, MDA-MB-468) resulted in a 
significant increase in chimeric organoid formation at 1 (**p < 0.001) and 2 weeks (*p < 0.01) 
(Table 2.). Furthermore, tumorigenic cell-deposits located in between ‘normal’ MCF-12A cell-
deposits appear to conform to the linear growth pattern directed by organoid ‘fusion’ determined 
by the print geometry. This method may provide a potential means to recapitulate the effect of 
developing tissue environments, and as such it could offer an effective method to improve studies 
of tumor cell behavior. Given our ability to deposit multiple cell types, reliably generate chimeric 
organoids, and provide evidence of the ability of MCF-12A organoids to influence neighboring 
tumorigenic cell behavior, we believe we were successful in completing the third objective of this 
work.  
5.2 Additional Considerations for Future Research 
Previous investigations into the early events of 3D morphogenesis of human MECs 
revealed that 3D structures undergo a coordinated rotational movement, and this process is 
required for assembly of laminins and collagen around the 3D structures37. This rotational motion 
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was independent of the cell cycle, and was directly related to the assembly of endogenous BM 
around the 3D structures37. Furthermore, structures formed by cancer-derived cell lines failed to 
display rotational motion, and were defective in weaving exogenous laminin matrix37. 
Interestingly, dissolution of BM around mature, nonrotating acini, restored rotational movement 
and the ability to assemble exogenous laminin37. Together, these findings indicate that coordinated 
rotational motion during 3D morphogenesis of MEC acini is a significant, regulating feature of the 
BM assembly process.  
Given the importance of rotational motion in developing MEC tissues, we utilized time-
lapse imaging surveys of developing, bioprinted, MEC structures to determine the presence of 
rotational motion. Throughout the first week of culture, data indicated our bioprinted MEC cell 
aggregates underwent coordinated, cell-cell interactions to produce a rotational motion in the 
direction of forward growth (Sup. Movie 3.1). Overall, it appears that the process of rotational 
motion may be intimately related to the collective migration of cells. Similar to the way water 
flows out of a spring to form a river, cells appear to ‘flow’ across the entire organoid structure in 
the direction of active growth (Sup. Movie 3.2). Given our bioprinted MEC organoids exhibit 
collective, rotational motion, we believe this data provides evidence in support of our primary goal 
of validating our 3D bioprinting technology for generating MEC organoids. While the role of 
rotational motion in establishing a properly assembled BM is not fully understood, in future 
studies, our bioprinting technology stands as an ideal platform to controllably investigate and 
understand the mechanisms that regulate cell-cell and cell-matrix interactions, despite their state 
of constant flux. 
Throughout our investigation to develop methods to reliably maintain cell-deposits inside 
a 3D hydrogel, we noted microneedle geometries with taper lengths less than the programmed 
insertion depth of the needle tip typically resulted in a broad circular deformation on the top of the 
collagen I gel. While this increase in gel-deformation did not alter the ability of our bioprinter to 
maintain cells in the target area, MECs were able to follow this opening and proliferate in the 2D 
environment on-top of the gel. Interestingly, these cells would then encompass the deformed, 
needle insertion point while maintaining cell-cell linkage with the developing organoid-structure 
deep within the gel.  This process resulted in the generation of individual ‘sprout-like’ structures 
at each injection site in the 3D gel. Using time-lapse imaging to track the behavior of migrating 
cells inside these ‘sprout-like’ structures, we found the cells within the tips of these structures 
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appeared to uniformly rotate in a ‘fluid-like’ motion associated with BM assembly37(Sup. Movie 
5.1). Throughout the culture period, the initial ‘sprout’ grew in diameter and length to resemble 
TEB structures seen in vivo (Fig. 25a). Further, some of these structures began to form secondary 
branches, indicating that these structures were not just artifacts from the needle insertion routine 
(Sup. Movie 5.1). The rotational motion was always perpendicular to the direction of the 
elongating duct (Fig. 25b). Additionally, the rotational motion was observed in both clockwise and 
counterclockwise directions among neighboring ‘TEB-like’ structures (Sup. Movie 5.1). 
Similar ‘TEB-like’ structures resulted using MCF-7 and MDA-MB-468 tumorigenic cell 
lines, which suggests this effect is conserved across multiple mammary cell lines, albeit without 
secondary branches or rotational motion (Fig. 25c,d). Similar to the numerous, previously stated 
discrepancies among the two tumor cell lines, both tumor cell lines exhibited unique growth 
morphologies under these conditions. While the overall shape of the structures from MDA-MB-
468 cells were similar to MCF-12A structures, the appearance of MDA-MB-468 structures was 
less smooth due to the presence of extensive fingerlike projections. ‘TEB-like’ structures of MCF-
7 cells were long narrow tubes, with what appears to be consistent, tightly woven cell-cell contacts 
(Fig. 25d). While the meaning of this unexpected, yet interesting result has not been thoroughly 
investigated, we noted this process would only occur when a hole was maintained between the 
inside and outside layer of the gel. Could the physical presence of an ‘opening’ provide instructive 
cues for the initial polarization and lumen formation in the developing mammary epithelium? 
Indeed, for every functional mammary gland, an ‘opening’ must be created to the outside through 
the nipple. The nipple is where the fetal epidermis initially invaginates into the mammary fat pad, 
and as such it represents the growth point origin of the mammary epithelium. We also find it 
interesting to note that the mammary glands of male rats develop similarly to females but have no 
external connection to the epidermis. While we currently do not know what processes control the 
formation of the nipple ‘opening’ through the skin above the fetal anlage, the physical deformation 
of gel materials, similar to the disruption of gel materials described above, certainly presents one 






Fig. 32.  Bioprinted breast organoids form ‘TEB-like’ morphologies. ‘TEB-like’ 
morphology results when cell-deposits are able to maintain linkage to the surface of 3D 
gels. (a) Section of a developing mouse mammary gland. Black arrows point to ‘TEB’ 
structures. Scale bar 1 mm. (b) ‘TEB-like’ structures grown in vitro after 14 days in culture 
using MCF-12A cells. Black arrows point to rounded cell mass located at the end of ‘stalk-
like’ structure. Scale bar 500µm. Tumorigenic cell lines MDA-MB-468 (c) and MCF-7 (d) 
also formed similar ‘TEB-like’ structures at 14 days. Scale bar 500µm. 
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5.3 Future Directions for Bioprinting in MEC Research 
One of the most iconic, yet mysterious structures in the mammary system is the TEB. The 
environment created by the TEB appears to elicit important features of regulatory signaling in the 
developing gland. For example, the TEB is the regulatory control point for basement membrane 
deposition, branching, angiogenesis, and pattern formation8,10. Also, the signaling pathways which 
drive and regulate the directional growth and motility of TEBs are responsible for establishing the 
primary structure of the entire mammary tree16. Despite advances in our understanding of the 
genetic regulation of mammary development3, the cellular basis of ductal elongation of bifurcation 
remains unknown. Active TEBs are also of a special interest, due to their ability to recruit stromal 
cells, heterogeneous cellular composition, invasive ability, angiogenic properties, and high 
proliferation rate (60-90%)10. Thus, any method that would create an in vitro model of the 
developing TEB, would represent an ideal model of the constant flux among cell-cell and cell-
matrix interactions that regulate mammary gland growth and development. Furthermore, given 
90% of human mammary cancers are of ductal origin, fully understanding the processes related to 
ductal growth would represent a significant advancement in the battle against breast cancer. 
Additional areas of research should also focus on determining the contribution of cell types 
outside of the epithelium compartment in the development and function of the mammary gland. 
As our bioprinting device has the capability to place multiple cell types within close proximity, it 
stands as an optimal candidate to systematically investigate the impact of additional cell types on 
MEC behavior. 
While our extrusion based bioprinting device has been able to achieve the reliable control 
of small cell quantities, our current bioprinting technology is still affected by cell settling due to 
the force of gravity. A solution to this can be as simple as increasing the viscosity of the cell 
containing bio-ink. This would also increase the extrusion force, which may negatively impact the 
extrusion process. For this reason, limiting the effect of cell settling stands as a key area to advance 
this technology. 
Another method to improve our current bioprinting technology could come from 
incorporating cell surface marker sorting technology into the injection device. This would provide 
the capability to isolate and select specific cell populations during the printing process. 
Additionally, current cell sorting approaches have been known to vary between studies, which 
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makes quantitative comparisons of the prevalence of different populations difficult3. For example, 
a tenfold increase in gland reconstitution in one study was shown to be related to transplant 
conditions, suggestive of the dramatic effect of transplant conditions on reconstitution 
efficiency149. Thus, incorporating this technology with bioprinting devices would have a 
significant impact on performing assays designed to identify the different epithelial cell 
populations with stem cell properties. As stem cells are intimately related to normal development 
and tissue pathologies, future studies will require methods for evaluating the role of these cells 
during mammary development and cancer. 
One of the greatest impacts of bioprinting technology is the high-throughput generation of 
3D cultures. However, the increased proficiency in generating 3D cultures means nothing if there 
is no equally matched system to analyze results. To this end, incorporating artificial intelligence 
and machine learning algorithms to systematically measure experimental results, such as 
histological slides and 3D image stacks, stands as the most logical method to retain consistency 
among thousands of experiments. However, just like the need to ‘tailor-fit’ 3D culture conditions 
to the cell type, these algorithms must be fine-tuned and maintained for each individual 
experiment. For example, traditional methods for measuring Ki67 staining rely on observer 
discretion. While routine training can help control inter-observer variance, the amount of Ki67 
bound nuclei is better represented with a ratio scale than a nominal scale (binary: yes/no). One 
could understand how setting a numerical threshold in an algorithm would result in a significant 
improvement in scoring data. We have begun to incorporate these protocols for analyzing 
histological sections and other large 3D image stacks. For example, in the case of Ki67 staining, 
we can utilize specific features of DAPI stained nuclei to detect and label each nucleus in any 
given slide (Fig. 33a1-a2). Next, these labels can be overlaid onto the original Ki67 image (Fig. 
33a3-a4). This method allows us to determine the corrected total cell flux for each nucleus in the 
sample, which provides more specific quantification of overall Ki67 activation.  
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Fig. 33. Algorithm to standardize measurement of histological data. (a) To measure Ki-67 
staining, nuclei (a1) are identified and counted to make a mask (a2) which can then be 
applied to Ki-67 staining (a3) to determine scoring data. (b) Isolating sub-populations in 
histological slides. (b1) GFP labeled MCF-7 cells inside chimeric organoid. (b2) β-catenin 
staining of chimeric organoid. (b3) MCF-7 cell population identified by algorithm. (b4) 
MCF-7 cell area subtracted from original β-catenin image. Scale bar 50µm. 
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Furthermore, this method can be utilized for additional proteins and histological assays. 
For example, consider GFP-labeled, MCF-7 cells in chimeric organoids (Fig. 33b1). Given the 
overall expression of β-catenin in a single histological slide (Fig. 33b2), if we identify the GFP-
labeled MCF-7 cells (Fig. 33b3) and remove these objects from the original β-catenin image (Fig. 
33b4), we can isolate the region of a distinct member from the original image. Similar to the Ki67 
protocol, we can then calculate the corrected total cell flux for just the MCF-7 cells or MCF-12A 
cell population. Using this method, large batch analysis of experimental conditions can be 
simultaneously, and quantitatively compared without observer bias, which ultimately function to 
reduce both intra and inter-laboratory variance. 
5.4 Conclusion 
Overall, the future challenge for mammary research is to place the genes and proteins they 
encode into the larger picture of mammary development and function. Pertinent to this task of 
understanding the physiological significance of the unique proteins in the puzzle of mammary 
gland development will be the introduction of in vitro approaches that use genetically manipulated 
primary cells or cell lines to form a functional epithelium. Further, these in vitro constructs could 
then be implanted in vivo to define their position in the signaling networks related to mammary 
gland development. Furthering our use and development of these systems will be invaluable in 
modelling tumor progression and testing pharmacological agents in a biologically relevant context. 
Here we detailed the custom-design and use of 3D bioprinting systems to improve upon 
conventional methods for studying tumor cell behaviors in 3D assays. These results indicate 
microfabrication techniques have the potential to become valuable tools in mimicking distinct 
properties of the in vivo situation. We expect the use of these systems will provide new 
perspectives and opportunities for future research design.  
Investigating the histological patterns of both invasive and preinvasive tumors associated 
with breast carcinomas stands as a highly valuable means of obtaining prognostic information. As 
much remains to be learned about how the genotypic abnormalities associated with cancer elicit 
the phenotypic changes related to tumorigenesis, any technology capable of systematically 
investigating these mechanisms will be useful. Through the imaginative, new perspectives and 
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opportunities provided by bioprinting techniques, we are currently working on utilizing these 
microfabrication techniques as a tool for mimicking distinct properties of the in vivo situation. 
Thus, our bioprinting platform would provide the ideal method to generate high-throughput assays 
of primary tumor cells from patient biopsies. Therefore, in addition to acting as a multipurpose 
technique for a range of applications including biomedical implants and tissue engineering, we 
believe the greatest impact of 3D bioprinting technology may come from the potential service as 
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APPENDICES 
APPENDIX A: GELATION PROTOCOL FOR COLLAGEN I, RAT TAIL 
Place on ice the following: 
1.1 Corning Collagen I, rat tail 
1.2 Sterile phosphate buffered saline (PBS) 
1.3 Sterile 1 N NaOH 
1.4 Sterile tube of sufficient capacity 
2.0 Determine the Desired Collagen Concentration (mg/mL).  
3.0 Determine the total volume of Collagen I solution required to perform the experiment (V-
total) 
4.0 Place on ice a sterile tube of sufficient capacity to contain the final volume of Collagen I 
(Vtotal). 
5.0 Use the following equation to calculate the volume of stock collagen (Vstock) to achieve the  
Desired Collagen Concentration (step 2.0) and the total volume of collagen I solution (Vtotal) 
required for the experiment (step 3.0). 
 




)  ×  (𝑉𝑡𝑜𝑡𝑎𝑙 𝑚𝐿)





6.0 Determine the volume of sterile, ice cold 1 N NaOH required for the experiment (VNaOH). 
𝑉𝑜𝑙𝑢𝑚𝑒 𝑜𝑓 𝑁𝑎𝑂𝐻 (𝑉𝑁𝑎𝑂𝐻) = 𝑉 𝑠𝑡𝑜𝑐𝑘(𝑚𝐿) × 0.023 𝑚𝐿  
 
7.0 Next, determine the volume of PBS required for the experiment (VPBS) by subtracting V-
NaOH and Vstock (step 5.0 & 6.0) from the total volume of collagen I solution required for the 
experiment Vtotal (step 3.0). 
 
𝑉𝑜𝑙𝑢𝑚𝑒 𝑜𝑓 𝑃𝐵𝑆 (𝑉𝑃𝐵𝑆) = 𝑉𝑡𝑜𝑡𝑎𝑙  −  𝑉𝑠𝑡𝑜𝑐𝑘 − 𝑉𝑁𝑎𝑂𝐻 
 
8.0 Perform the following steps, in the provided order, using aseptic technique. 
8.1 Add the required volume of sterile, ice-cold PBS (VPBS) to the sterile tube on ice. 
8.2 Next, add the required volume of sterile, ice-cold 1 N NaOH (VNaOH) to the volume of PBS 
(VPBS). 
8.3 Mix the contents of tube and place in ice. 
8.4 Add the calculated volume of stock collagen (Vstock), mix, and leave on ice until ready for 
use. 
9.0 Aseptically deliver collagen solution into cell culture device and allow to get at 37°C for 
at least 30 minutes prior to printing. If not used immediately, collagen solution may be held on 
ice for 2-3 hours.
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